Pular para o conteúdo
Imunodeficiência primária
ORPHA:101997PCDT · SUSDOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Dermatológico
Também conhecida comoImunodeficiência congénita

Uma condição em que o sistema de defesa do corpo não consegue se defender adequadamente.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A imunodeficiência primária, conhecida também como imunodeficiência congénita, é uma condição em que o sistema de defesa natural do organismo não funciona como deveria. Por causa dessa falha imunológica, a pessoa pode ter infecções respiratórias frequentes, infecções causadas por germes oportunistas e alterações em unhas e pele. O diagnóstico envolve exames detalhados do sangue para avaliar as células imunes e investigação de alterações em genes específicos. No Brasil, o Sistema Único de Saúde (SUS) disponibiliza e entrega a imunoglobulina humana por via intravenosa ou subcutânea através do CEAF para os casos indicados em protocolo oficial.

📋
Informacoes curadas por IA — podem conter imprecisoes

Uma condição em que o sistema de defesa do corpo não consegue se defender adequadamente.

Pesquisas ativas
38 ensaios
134 total registrados no ClinicalTrials.gov
Publicações científicas
6.203 artigos
Último publicado: 2026 Apr
Medicamentos
3 com registro
Imunoglobulina humana IV, Imunoglobulina humana SC, FEMIGESTROL

Tem tratamento?

✓ 3 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
IMUNOGLOBULINA HUMANA IVIMUNOGLOBULINA HUMANA SCFEMIGESTROL
Mais 10 moléculas em estudo para esta doença.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
🏥
SUS: Cobertura parcialScore: 50%
PCDT disponível2 medicamentos CEAF
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
104 sintomas
🫃
Digestivo
83 sintomas
🩸
Sangue
81 sintomas
🧬
Pele e cabelo
77 sintomas
🧠
Neurológico
73 sintomas
😀
Face
47 sintomas

+ 602 sintomas em outras categorias

Características mais comuns

—
Infecções respiratórias recorrentes
—
Xantelasma
—
Hemofagocitose esplênica
—
Ulceração jejunoileal
—
Dilatação
—
Infecção oportunista
1357sintomas
Sem dados (1357)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1357 características clínicas mais associadas, ordenadas por frequência.

Infecções respiratórias recorrentesRecurrent respiratory infections
XantelasmaXanthelasma
Hemofagocitose esplênicaSplenic hemophagocytosis
Ulceração jejunoilealJejunoileal ulceration
DilataçãoDilatation

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico6.203PubMed
Últimos 10 anos200publicações
Pico2026115 papers
Linha do tempo
2026Hoje · 2026🧪 1991Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

85 genes identificados com associação a esta condição.

Curadoria gene-doença

fontes oficiais
STXBP3TRIM22
PanelApp · Primary immunodeficiency or monogenic inflammatory bowel diseaseGenomics England
ACD ACP5 ADA ADA2 ADAM17 ADAR AGR2 AICDA AIRE AK2 ALPI ALPK1 ANKZF1 AP3B1 ARPC1B ARPC5 ATM ATP6AP1 B2M BACH2 BCL10 BLM BLNK BLOC1S6 BTK C17orf62 C1QA C1QB C1QC C1R C1S C2 C2orf69 C3 C4A C4B C5 C6 C7 C8A C8B C9 CARD11 CARD14 CARD9 CARMIL2 CASP8 CBLB CCBE1 CD19 CD247 CD27 CD3D CD3E CD3G CD4 CD40 CD40LG CD46 CD55 CD59 CD70 CD79A CD79B CD81 CDC42 CDCA7 CEBPE CFD CFH CFI CFP CHD7 CIB1 CIITA CLPB COL7A1 COPA CORO1A CR2 CREBBP CSF2RA CSF2RB CSF3R CTLA4 CTPS1 CTSC CXCR2 CXCR4 CYBA CYBB DBR1 DCLRE1C DEF6 DIAPH1 DKC1 DNAJC21 DNASE1L3 DNASE2 DNMT3B DOCK11 DOCK2 DOCK8 DPP9 DUT EFL1 ELANE ELF4 EP300 EPG5 ERCC6L2 EXTL3 F12 FADD FAS FASLG FAT4 FCHO1 FERMT1 FERMT3 FNIP1 FOXN1 FOXP3 G6PC3 G6PD GATA1 GATA2 GFI1 GINS1 GNAI2 GUCY2C HAVCR2 HAX1 HELLS HMOX1 HPS1 HPS4 HPS6 HTRA2 HYOU1 ICOS IFIH1 IFNAR1 IFNAR2 IFNGR1 IFNGR2 IGHM IGLL1 IKBKB IKBKG IKZF1 IKZF2 IKZF3 IL10 IL10RA IL10RB IL12B IL12RB1 IL17RA IL17RC IL1RN IL21R IL23R IL2RA IL2RB IL2RG IL36RN IL6R IL6ST IL7 IL7R IRAK4 IRF1 IRF2BP2 IRF4 IRF7 IRF8 ISG15 ITCH ITGB2 ITK ITPR3 JAGN1 JAK1 JAK3 KDM6A KMT2A KMT2D LACC1 LAMTOR2 LAT LCK LCP2 LIG1 LIG4 LPIN2 LRBA LYN LYST MAGT1 MALT1 MAP3K14 MCM4 MCTS1 MECOM MEFV MOGS MPEG1 MSN MTHFD1 MVK MYD88 MYO5B MYSM1 NBN NCF1 NCF2 NCF4 NCKAP1L NFAT5 NFE2L2 NFKB1 NFKB2 NFKBIA NHEJ1 NHP2 NLRC4 NLRP1 NLRP12 NLRP3 NOD2 NPC1 NSMCE3 NUDCD3 OAS1 ORAI1 OTULIN PARN PAX1 PEPD PGM3 PI4KA PIK3CD PIK3CG PIK3R1 PLCG2 PLG PNP POLA1 POLD1 POLE POMP PRF1 PRIM1 PRKCD PRKDC PSMB10 PSMB8 PSTPIP1 PTCRA PTPN2 PTPRC RAB27A RAC2 RAG1 RAG2 RANBP2 RASGRP1 RBCK1 RECQL4 REL RELA RELB RFX5 RFXANK RFXAP RIPK1 RMRP RNASEH2A RNASEH2B RNASEH2C RNF168 RNU7-1 RORC RPSA RTEL1 SAMD9 SAMD9L SAMHD1 SASH3 SBDS SEC61A1 SERPING1 SGPL1 SH2D1A SKIV2L SLC29A3 SLC35C1 SLC37A4 SLC39A4 SLC39A7 SLC46A1 SLC7A7 SLCO2A1 SMARCAL1 SMARCD2 SNORA31 SOCS1 SP110 SPI1 SPINK5 SPPL2A SRP54 STAT1 STAT2 STAT3 STAT4 STAT5B STAT6 STIM1 STK4 STX11 STXBP2 STXBP3 SYK TAP1 TAP2 TAZ TBK1 TBX1 TCF3 TCN2 TET2 TFRC TGFB1 TGFBR1 TGFBR2 TICAM1 TLR3 TLR7 TLR8 TMC6 TMC8 TMEFF1 TMEM173 TNFAIP3 TNFRSF1A TNFRSF9 TOP2B TPP2 TRAC TRAF3 TRAF3IP2 TREX1 TRIM22 TRNT1 TTC37 TTC7A TYK2 UNC13D UNC93B1 UNG USB1 USP18 VPS13B VPS45 WAS WDR1 WIPF1 XIAP ZAP70 ZBTB24 ZNF341 ZNFX1 ANGPT1 AP1S3 AP3D1 ATAD3A BCL11B BRF2 CARD8 CASP10 CD8A CFB CFTR CTC1 DCLRE1B ERBIN FCGR3A FGL2 FLT3LG FMNL2 FOXI3 FPR1 GCC2 GIMAP5 GTF3A HSPA1L IGKC IL17F IL1R1 IL21 IL27RA IPO8 IRF3 IRF9 ITGAV ITPKB IVNS1ABP KCNA5 KRAS MAN2B2 MBL2 MKL1 MPO NCSTN NOP10 NRAS POLD3 POLR3A POLR3C PSENEN PSMA3 PSMB4 PSMB9 PTEN QSOX2 RC3H1 REXO2 RHBDF2 RHOH RNF31 RNU4ATAC RNU6ATAC SCGN SENP7 SLC19A1 SLC30A2 SLC9A3 SRP72 TAPBP TERC TERT TINF2 TNFRSF11A TNFRSF13C
ZNF341Zinc finger protein 341Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections

An immunologic disorder characterized by skin bacterial infections in particular with Staphylococcus aureus, susceptibility to fungal infections such as chronic mucocutaneous candidiasis, atopic dermatitis, recurrent respiratory infections, bronchiectasis, and increased serum IgE and IgG. Immunologic work-up shows impaired differentiation of CD4+ T cells into T-helper 17 cells, decreased memory B cells, and often decreased NK cells. Some patients manifest extrahemapoietic features, including facial dysmorphism, abnormal dentition, alopecia, joint hypermobility and bone fractures. Disease onset is in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
9.9 TPM
Cérebro - Hemisfério cerebelar
9.5 TPM
Testículo
8.6 TPM
Baço
8.0 TPM
Próstata
7.8 TPM
OUTRAS DOENÇAS (1)
hyper-IgE recurrent infection syndrome 3, autosomal recessive
HGNC:15992UniProt:Q9BYN7
CARD11Caspase recruitment domain-containing protein 11Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Downstream TCR signalingActivation of NF-kappaB in B cells
MECANISMO DE DOENÇA

B-cell expansion with NFKB and T-cell anergy

An autosomal dominant condition characterized by onset in infancy of splenomegaly and polyclonal expansion of B cells, resulting in peripheral lymphocytosis. Affected individuals also show mild immune dysfunction, including some defective antibody responses and T-cell anergy. There may be a predisposition to the development of B-cell malignancy.

OUTRAS DOENÇAS (5)
immunodeficiency 11b with atopic dermatitissevere combined immunodeficiency due to CARD11 deficiencyBENTA diseaseCADINS disease
HGNC:16393UniProt:Q9BXL7
IGLL1Immunoglobulin lambda-like polypeptide 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Cell surface interactions at the vascular wall
MECANISMO DE DOENÇA

Agammaglobulinemia 2, autosomal recessive

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
42.3 TPM
Baço
0.8 TPM
Sangue
0.4 TPM
Cérebro - Hemisfério cerebelar
0.3 TPM
Glândula salivar
0.3 TPM
OUTRAS DOENÇAS (2)
agammaglobulinemia 2, autosomal recessiveautosomal agammaglobulinemia
HGNC:5870UniProt:P15814
CD79BB-cell antigen receptor complex-associated protein beta chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
MECANISMO DE DOENÇA

Agammaglobulinemia 6, autosomal recessive

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

OUTRAS DOENÇAS (2)
agammaglobulinemia 6, autosomal recessiveautosomal agammaglobulinemia
HGNC:1699UniProt:P40259
DGKEDiacylglycerol kinase epsilonCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Effects of PIP2 hydrolysis
MECANISMO DE DOENÇA

Nephrotic syndrome 7

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. NPHS7 is an autosomal recessive form characterized by onset of proteinuria usually in the first decade of life. The disorder is progressive, and some patients develop end-stage renal disease within several years. Renal biopsy typically shows membranoproliferative glomerulonephritis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
20.3 TPM
Cerebelo
15.9 TPM
Útero
10.9 TPM
Pituitária
10.6 TPM
Cervix Ectocervix
10.4 TPM
OUTRAS DOENÇAS (2)
immunoglobulin-mediated membranoproliferative glomerulonephritisatypical hemolytic-uremic syndrome with DGKE deficiency
HGNC:2852UniProt:P52429
CASP8Caspase-8Candidate gene tested inTolerante
VIAS BIOLÓGICAS (10)
NOD1/2 Signaling PathwayNF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10Caspase activation via Death Receptors in the presence of ligandDimerization of procaspase-8TRIF-mediated programmed cell death
MECANISMO DE DOENÇA

Caspase-8 deficiency

Disorder resembling autoimmune lymphoproliferative syndrome (ALPS). It is characterized by lymphadenopathy, splenomegaly, and defective CD95-induced apoptosis of peripheral blood lymphocytes (PBLs). It leads to defects in activation of T-lymphocytes, B-lymphocytes, and natural killer cells leading to immunodeficiency characterized by recurrent sinopulmonary and herpes simplex virus infections and poor responses to immunization.

OUTRAS DOENÇAS (5)
hepatocellular carcinomaautoimmune lymphoproliferative syndrome type 2Badult hepatocellular carcinomahereditary breast carcinoma
HGNC:1509UniProt:Q14790
NFAT5Nuclear factor of activated T-cells 5Candidate gene tested inAltamente restrito
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
22.7 TPM
Cervix Endocervix
22.5 TPM
Útero
21.3 TPM
Linfócitos
21.1 TPM
Fibroblastos
19.1 TPM
OUTRAS DOENÇAS (1)
inflammatory bowel disease-recurrent sinopulmonary infections syndrome
HGNC:7774UniProt:O94916
CD70CD70 antigenCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Lymphoproliferative syndrome 3

An autosomal recessive, early-onset immunologic disorder characterized by increased susceptibility to Epstein-Barr virus infection in B cells, abnormal B-cell proliferation and increased susceptibility to B-cell malignancies, including Hodgkin lymphoma. Patients usually have lymphadenopathy and hypogammaglobulinemia, and may suffer from recurrent infections.

OUTRAS DOENÇAS (1)
severe combined immunodeficiency due to CD70 deficiency
HGNC:11937UniProt:P32970
IFNAR2Interferon alpha/beta receptor 2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (5)
Interferon alpha/beta signalingSARS-CoV-2 activates/modulates innate and adaptive immune responsesRegulation of IFNA/IFNB signalingEvasion by RSV of host interferon responsesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Immunodeficiency 45

An autosomal recessive disorder characterized by increased susceptibility to viral infection due to impaired antiviral immunity, resulting in infection-associated encephalopathy. Affected individuals are at risk for developing fatal encephalitis after routine measles/mumps/rubella (MMR) vaccination.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
66.7 TPM
Baço
40.4 TPM
Sangue
30.4 TPM
Nervo tibial
29.9 TPM
Pulmão
28.5 TPM
OUTRAS DOENÇAS (3)
immunodeficiency 45primary immunodeficiency with post-measles-mumps-rubella vaccine viral infectionhepatitis B virus, susceptibility to
HGNC:5433UniProt:P48551
IL21Interleukin-21Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Interleukin-21 signaling
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 11

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.4 TPM
OUTRAS DOENÇAS (1)
IL21-related infantile inflammatory bowel disease
HGNC:6005UniProt:Q9HBE4
SPI1Transcription factor PU.1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Transcriptional regulation of granulopoiesisRUNX1 regulates transcription of genes involved in differentiation of HSCs
MECANISMO DE DOENÇA

Agammaglobulinemia 10, autosomal dominant

A form of agammaglobulinemia, a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
873.5 TPM
Baço
187.1 TPM
Pulmão
127.9 TPM
Linfócitos
36.9 TPM
Adipose Visceral Omentum
33.2 TPM
OUTRAS DOENÇAS (2)
agammaglobulinemia 10, autosomal dominantautosomal agammaglobulinemia
HGNC:11241UniProt:P17947
IL6STInterleukin-6 receptor subunit betaCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (4)
Interleukin-6 signalingInterleukin-27 signalingIL-6-type cytokine receptor ligand interactionsInterleukin-35 Signalling
MECANISMO DE DOENÇA

Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections

An immunologic disorder characterized by recurrent mainly sino-pulmonary infections associated with increased serum IgE. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
214.0 TPM
Adipose Visceral Omentum
117.2 TPM
Pulmão
116.9 TPM
Nervo tibial
116.5 TPM
Tecido adiposo
113.4 TPM
OUTRAS DOENÇAS (7)
Stuve-Wiedemann syndrome 2hyper-IgE recurrent infection syndrome 4A, autosomal dominanthyper-IgE recurrent infection syndrome 4, autosomal recessiveimmunodeficiency 94 with autoinflammation and dysmorphic facies
HGNC:6021UniProt:P40189
KNSTRNSmall kinetochore-associated proteinCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Roifman-Chitayat syndrome

An autosomal recessive digenic disorder characterized by global developmental delay, variable neurologic features such as seizures and ataxia, optic atrophy, dysmorphic facial features, distal skeletal anomalies, and recurrent invasive infections due to combined immunodeficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
94.2 TPM
Tireoide
76.5 TPM
Linfócitos
35.8 TPM
Fibroblastos
20.4 TPM
Cérebro - Hemisfério cerebelar
14.9 TPM
OUTRAS DOENÇAS (1)
combined immunodeficiency with faciooculoskeletal anomalies
HGNC:30767UniProt:Q9Y448
LRBALipopolysaccharide-responsive and beige-like anchor proteinCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 8, with autoimmunity

An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early-childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
36.2 TPM
Skin Sun Exposed Lower leg
19.1 TPM
Pituitária
18.1 TPM
Skin Not Sun Exposed Suprapubic
18.1 TPM
Esôfago - Mucosa
16.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
combined immunodeficiency due to LRBA deficiency
HGNC:1742UniProt:P50851
AP3B1AP-3 complex subunit beta-1Candidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 2

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS2 differs from the other forms of HPS in that it includes immunodeficiency in its phenotype and patients with HPS2 have an increased susceptibility to infections.

OUTRAS DOENÇAS (1)
Hermansky-Pudlak syndrome 2
HGNC:566UniProt:O00203
C8BComplement component C8 beta chainCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Regulation of Complement cascadeTerminal pathway of complement
MECANISMO DE DOENÇA

Complement component 8 deficiency, 2

A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis.

OUTRAS DOENÇAS (2)
type II complement component 8 deficiencyimmunodeficiency due to a late component of complement deficiency
HGNC:1353UniProt:P07358
C1RComplement C1r subcomponentCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
Initial triggering of complementClassical antibody-mediated complement activationRegulation of Complement cascade
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, periodontal type, 1

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSPD1 is characterized by the association of typical features of Ehlers-Danlos syndrome with gingival recession and severe early-onset periodontal disease, leading to premature loss of permanent teeth. EDSPD1 inheritance is autosomal dominant.

OUTRAS DOENÇAS (4)
Ehlers-Danlos syndrome, periodontal type 1immunodeficiency due to a classical component pathway complement deficiencyEhlers-Danlos syndrome, periodontitis typeautosomal systemic lupus erythematosus type 16
HGNC:1246UniProt:P00736
C1SComplement C1s subcomponentCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
Initial triggering of complementClassical antibody-mediated complement activationRegulation of Complement cascade
MECANISMO DE DOENÇA

Complement component C1s deficiency

A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis.

OUTRAS DOENÇAS (4)
Ehlers-Danlos syndrome, periodontal type 2complement component C1s deficiencyEhlers-Danlos syndrome, periodontitis typeimmunodeficiency due to a classical component pathway complement deficiency
HGNC:1247UniProt:P09871
C4BComplement C4-BCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Systemic lupus erythematosus

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

OUTRAS DOENÇAS (3)
complement component 4b deficiencyimmunodeficiency due to a classical component pathway complement deficiencysystemic lupus erythematosus
HGNC:1324UniProt:P0C0L5
LRRC8AVolume-regulated anion channel subunit LRRC8ACandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Miscellaneous transport and binding events
MECANISMO DE DOENÇA

Agammaglobulinemia 5, autosomal dominant

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
126.3 TPM
Artéria tibial
104.0 TPM
Cerebelo
88.9 TPM
Esôfago - Mucosa
76.8 TPM
Pulmão
73.6 TPM
OUTRAS DOENÇAS (2)
agammaglobulinemia 5, autosomal dominantautosomal agammaglobulinemia
HGNC:19027UniProt:Q8IWT6
ERBINErbinCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
RAC3 GTPase cycleRHOG GTPase cycleRHOB GTPase cycleRAC1 GTPase cycleRAC2 GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
43.8 TPM
Brain Spinal cord cervical c-1
41.7 TPM
Nervo tibial
36.2 TPM
Linfócitos
34.0 TPM
Substância negra
31.9 TPM
OUTRAS DOENÇAS (1)
autosomal dominant combined immunodeficiency due to ERBIN deficiency
HGNC:15842UniProt:Q96RT1
BLNKB-cell linker proteinCandidate gene tested inRestrito
VIAS BIOLÓGICAS (2)
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersRegulation of signaling by CBL
MECANISMO DE DOENÇA

Agammaglobulinemia 4, autosomal recessive

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

OUTRAS DOENÇAS (2)
agammaglobulinemia 4, autosomal recessiveautosomal agammaglobulinemia
HGNC:14211UniProt:Q8WV28
IGHMImmunoglobulin heavy constant muCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (4)
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersPotential therapeutics for SARSCD22 mediated BCR regulationCell surface interactions at the vascular wall
MECANISMO DE DOENÇA

Agammaglobulinemia 1, autosomal recessive

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
4259.1 TPM
Linfócitos
3865.1 TPM
Intestino delgado
1077.3 TPM
Sangue
258.7 TPM
Cólon transverso
210.7 TPM
OUTRAS DOENÇAS (2)
autosomal recessive agammaglobulinemia 1autosomal agammaglobulinemia
HGNC:5541UniProt:P01871
PIK3CDPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerAntigen activates B Cell Receptor (BCR) leading to generation of second messengersCD28 dependent PI3K/Akt signaling
MECANISMO DE DOENÇA

Immunodeficiency 14A with lymphoproliferation, autosomal dominant

A disorder characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, reduced immunoglobulin G2 levels in serum, and impaired vaccine responses.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
111.7 TPM
Sangue
96.7 TPM
Baço
83.9 TPM
Pulmão
24.0 TPM
Intestino delgado
15.7 TPM
OUTRAS DOENÇAS (4)
immunodeficiency 14immunodeficiency 14b, autosomal recessivecombined immunodeficiency with faciooculoskeletal anomaliesautosomal agammaglobulinemia
HGNC:8977UniProt:O00329
TCF3Transcription factor E2-alphaCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
Negative Regulation of CDH1 Gene TranscriptionRUNX1 regulates transcription of genes involved in differentiation of HSCsMyogenesis
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
103.5 TPM
Testículo
77.1 TPM
Baço
46.2 TPM
Cervix Endocervix
43.4 TPM
Fibroblastos
40.9 TPM
OUTRAS DOENÇAS (5)
agammaglobulinemia 8, autosomal dominantagammaglobulinemia 8b, autosomal recessiveautosomal agammaglobulinemiaB-lymphoblastic leukemia/lymphoma with t(17;19)
HGNC:11633UniProt:P15923
PRKCDProtein kinase C delta typeCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (9)
Interferon gamma signalingApoptotic cleavage of cellular proteinsVEGFR2 mediated cell proliferationRole of phospholipids in phagocytosisDAG and IP3 signaling
MECANISMO DE DOENÇA

Autoimmune lymphoproliferative syndrome 3

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. CVID9 patients have B-cell deficiency and severe autoimmunity.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
133.8 TPM
Linfócitos
106.4 TPM
Baço
82.6 TPM
Tireoide
81.7 TPM
Pulmão
73.4 TPM
OUTRAS DOENÇAS (1)
autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD
HGNC:9399UniProt:Q05655
IL6RInterleukin-6 receptor subunit alphaCandidate gene tested inTolerante
VIAS BIOLÓGICAS (6)
MAPK3 (ERK1) activationMAPK1 (ERK2) activationInterleukin-6 signalingPotential therapeutics for SARSTranscriptional regulation of granulopoiesis
MECANISMO DE DOENÇA

Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections

An immunologic disorder characterized by recurrent sinopulmonary and deep skin infections, mostly caused by bacteria, including H.influenza and S.aureus. Additional features include asthma, atopic dermatitis, and impaired inflammatory responses during infection. Disease onset is in early infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
67.2 TPM
Sangue
52.7 TPM
Fígado
38.0 TPM
Pulmão
29.4 TPM
Esôfago - Muscular
27.0 TPM
OUTRAS DOENÇAS (2)
hyper-IgE recurrent infection syndrome 5, autosomal recessiveautosomal recessive combined immunodeficiency due to IL6R deficiency
HGNC:6019UniProt:P08887
CFIComplement factor ICandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Hemolytic uremic syndrome, atypical, 3

An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease.

OUTRAS DOENÇAS (6)
complement factor I deficiencyDoyne honeycomb retinal dystrophyatypical hemolytic uremic syndrome with complement gene abnormalityHELLP syndrome
HGNC:5394UniProt:P05156
CD46Membrane cofactor proteinCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Hemolytic uremic syndrome, atypical, 2

An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease.

OUTRAS DOENÇAS (3)
HELLP syndromeatypical hemolytic uremic syndrome with complement gene abnormalityatypical hemolytic-uremic syndrome with MCP/CD46 anomaly
HGNC:6953UniProt:P15529
C3Complement C3Candidate gene tested inRestrito
VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Complement component 3 deficiency

A rare defect of the complement classical pathway. Patients develop recurrent, severe, pyogenic infections because of ineffective opsonization of pathogens. Some patients may also develop autoimmune disorders, such as arthralgia and vasculitic rashes, lupus-like syndrome and membranoproliferative glomerulonephritis.

OUTRAS DOENÇAS (4)
complement component 3 deficiencyatypical hemolytic uremic syndrome with complement gene abnormalityatypical hemolytic-uremic syndrome with C3 anomalyage related macular degeneration 9
HGNC:1318UniProt:P01024
THBDThrombomodulinCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (2)
Common Pathway of Fibrin Clot FormationCell surface interactions at the vascular wall
MECANISMO DE DOENÇA

Thrombophilia due to thrombomodulin defect

A hemostatic disorder characterized by a tendency to thrombosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
112.0 TPM
Pulmão
110.4 TPM
Skin Not Sun Exposed Suprapubic
108.2 TPM
Artéria coronária
91.3 TPM
Aorta
87.3 TPM
OUTRAS DOENÇAS (3)
thrombomodulin-related bleeding disorderatypical hemolytic uremic syndrome with complement gene abnormalityatypical hemolytic-uremic syndrome with thrombomodulin anomaly
HGNC:11784UniProt:P07204
C4AComplement C4-ACandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Complement component 4A deficiency

A rare defect of the complement classical pathway associated with the development of autoimmune disorders, mainly systemic lupus with or without associated glomerulonephritis.

OUTRAS DOENÇAS (5)
complement component 4a deficiencyBehcet diseaseimmunodeficiency due to a classical component pathway complement deficiencysystemic lupus erythematosus
HGNC:1323UniProt:P0C0L4
NFKBIANF-kappa-B inhibitor alphaCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
RIP-mediated NFkB activation via ZBP1TRAF6 mediated NF-kB activationTAK1-dependent IKK and NF-kappa-B activation NF-kB is activated and signals survivalCLEC7A (Dectin-1) signaling
MECANISMO DE DOENÇA

Ectodermal dysplasia and immunodeficiency 2

A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. This form of ectodermal dysplasia is associated with decreased production of pro-inflammatory cytokines and certain interferons, rendering patients susceptible to infection. EDAID2 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
497.5 TPM
Nervo tibial
450.8 TPM
Baço
352.8 TPM
Ovário
332.9 TPM
Skin Not Sun Exposed Suprapubic
320.1 TPM
OUTRAS DOENÇAS (5)
ectodermal dysplasia and immunodeficiency 2ectodermal dysplasia and immune deficiencygiant cell glioblastomanasopharyngeal carcinoma
HGNC:7797UniProt:P25963
LSM11U7 snRNA-associated Sm-like protein LSm11Candidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
SLBP independent Processing of Histone Pre-mRNAsRNA Polymerase II Transcription TerminationSLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
MECANISMO DE DOENÇA

Aicardi-Goutieres syndrome 8

A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood. AGS8 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
19.5 TPM
Bladder
17.4 TPM
Cérebro - Hemisfério cerebelar
16.2 TPM
Cerebelo
12.9 TPM
Útero
12.7 TPM
OUTRAS DOENÇAS (2)
Aicardi-Goutieres syndrome 8Aicardi-Goutieres syndrome
HGNC:30860UniProt:P83369
TREX1Three-prime repair exonuclease 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
IRF3-mediated induction of type I IFNRegulation by TREX1
MECANISMO DE DOENÇA

Aicardi-Goutieres syndrome 1

A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
80.6 TPM
Baço
45.2 TPM
Skin Sun Exposed Lower leg
42.6 TPM
Skin Not Sun Exposed Suprapubic
42.3 TPM
Pituitária
42.0 TPM
OUTRAS DOENÇAS (6)
retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationschilblain lupus 1Aicardi-Goutieres syndrome 1Aicardi-Goutieres syndrome
HGNC:12269UniProt:Q9NSU2
RNASEH2CRibonuclease H2 subunit CCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Aicardi-Goutieres syndrome 3

A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
70.5 TPM
Cérebro - Hemisfério cerebelar
68.3 TPM
Útero
67.2 TPM
Ovário
60.3 TPM
Cervix Endocervix
59.7 TPM
OUTRAS DOENÇAS (2)
Aicardi-Goutieres syndrome 3Aicardi-Goutieres syndrome
HGNC:24116UniProt:Q8TDP1
LYSTLysosomal-trafficking regulatorDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
RUNX2 regulates osteoblast differentiationFormation of the anterior neural plateFormation of the posterior neural plate
MECANISMO DE DOENÇA

Chediak-Higashi syndrome

A rare autosomal recessive disorder characterized by hypopigmentation, severe immunologic deficiency, a bleeding tendency, neurologic abnormalities, abnormal intracellular transport to and from the lysosome, and giant inclusion bodies in a variety of cell types. Most patients die at an early age unless they receive an allogeneic hematopoietic stem cell transplant (SCT).

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
14.6 TPM
Cerebelo
14.6 TPM
Nervo tibial
12.8 TPM
Tecido adiposo
12.7 TPM
Skin Not Sun Exposed Suprapubic
12.2 TPM
OUTRAS DOENÇAS (2)
Chediak-Higashi syndromeattenuated Chédiak-Higashi syndrome
HGNC:1968UniProt:Q99698
C5Complement C5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Activation of C3 and C5Regulation of Complement cascadeTerminal pathway of complement
MECANISMO DE DOENÇA

Complement component 5 deficiency

A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis.

OUTRAS DOENÇAS (3)
complement component 5 deficiencyobsolete eculizumab, poor response toimmunodeficiency due to a late component of complement deficiency
HGNC:1331UniProt:P01031
C2Complement C2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Initial triggering of complement
MECANISMO DE DOENÇA

Macular degeneration, age-related, 14

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

OUTRAS DOENÇAS (3)
complement component 2 deficiencyimmunodeficiency due to a classical component pathway complement deficiencyage related macular degeneration 14
HGNC:1248UniProt:P06681
SKIC3Superkiller complex protein 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
mRNA decay by 3' to 5' exoribonuclease
MECANISMO DE DOENÇA

Trichohepatoenteric syndrome 1

A syndrome characterized by intrauterine growth retardation, severe diarrhea in infancy requiring total parenteral nutrition, facial dysmorphism, immunodeficiency, and hair abnormalities, mostly trichorrhexis nodosa. Hepatic involvement contributes to the poor prognosis of affected patients.

OUTRAS DOENÇAS (2)
trichohepatoenteric syndrome 1trichohepatoenteric syndrome
HGNC:23639UniProt:Q6PGP7
SKIC2Superkiller complex protein 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
mRNA decay by 3' to 5' exoribonucleaseAssociation of TriC/CCT with target proteins during biosynthesis
MECANISMO DE DOENÇA

Trichohepatoenteric syndrome 2

A syndrome characterized by intrauterine growth retardation, severe diarrhea in infancy requiring total parenteral nutrition, facial dysmorphism, immunodeficiency, and hair abnormalities, mostly trichorrhexis nodosa. Hepatic involvement contributes to the poor prognosis of affected patients.

OUTRAS DOENÇAS (2)
trichohepatoenteric syndrome 2trichohepatoenteric syndrome
HGNC:10898UniProt:Q15477
XIAPE3 ubiquitin-protein ligase XIAPDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
RIPK1-mediated regulated necrosisTNFR1-induced proapoptotic signalingRegulation of TNFR1 signalingRegulation of necroptotic cell deathTNFR1-induced NF-kappa-B signaling pathway
MECANISMO DE DOENÇA

Lymphoproliferative syndrome, X-linked, 2

A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
18.3 TPM
Fibroblastos
17.6 TPM
Tireoide
16.3 TPM
Pulmão
15.7 TPM
Cervix Ectocervix
15.5 TPM
OUTRAS DOENÇAS (1)
X-linked lymphoproliferative disease due to XIAP deficiency
HGNC:592UniProt:P98170
SH2D1ASH2 domain-containing protein 1ADisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Lymphoproliferative syndrome, X-linked, 1

A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
9.3 TPM
Esôfago - Muscular
3.8 TPM
Pulmão
3.5 TPM
Sangue
3.4 TPM
Intestino delgado
2.1 TPM
OUTRAS DOENÇAS (1)
X-linked lymphoproliferative disease due to SH2D1A deficiency
HGNC:10820UniProt:O60880
BLOC1S6Biogenesis of lysosome-related organelles complex 1 subunit 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 9

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 9Hermansky-Pudlak syndrome 7
HGNC:8549UniProt:Q9UL45
NCF2Neutrophil cytosol factor 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
RHO GTPases Activate NADPH OxidasesVEGFA-VEGFR2 PathwayRAC3 GTPase cycleRAC1 GTPase cycleDetoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Granulomatous disease, chronic, autosomal recessive, 2

A form of chronic granulomatous disease, a primary immunodeficiency characterized by severe recurrent bacterial and fungal infections, along with manifestations of chronic granulomatous inflammation. It results from an impaired ability of phagocytes to mount a burst of reactive oxygen species in response to pathogens.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
639.6 TPM
Baço
104.7 TPM
Pulmão
89.4 TPM
Linfócitos
68.1 TPM
Adipose Visceral Omentum
17.8 TPM
OUTRAS DOENÇAS (2)
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2chronic granulomatous disease
HGNC:7661UniProt:P19878
CFPProperdinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Activation of C3 and C5Regulation of Complement cascadeAlternative complement activationNeutrophil degranulation
MECANISMO DE DOENÇA

Properdin deficiency

Results in higher susceptibility to bacterial infections; especially to meningococcal infections. Three phenotypes have been reported: complete deficiency (type I), incomplete deficiency (type II), and dysfunction of properdin (type III).

OUTRAS DOENÇAS (1)
properdin deficiency, X-linked
HGNC:8864UniProt:P27918
IGKCImmunoglobulin kappa constantDisease-causing germline mutation(s) inDesconhecido
VIAS BIOLÓGICAS (10)
Role of phospholipids in phagocytosisFCGR3A-mediated IL10 synthesisRegulation of actin dynamics for phagocytic cup formationFCGR activationInitial triggering of complement
MECANISMO DE DOENÇA

Immunoglobulin kappa light chain deficiency

A disease characterized by the complete absence of immunoglobulin kappa chains.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
26683.4 TPM
Glândula salivar
13358.3 TPM
Linfócitos
9372.4 TPM
Cólon transverso
8799.4 TPM
Intestino delgado
7899.3 TPM
OUTRAS DOENÇAS (1)
recurrent infections associated with rare immunoglobulin isotypes deficiency
HGNC:5716UniProt:P01834
TNFRSF13CTumor necrosis factor receptor superfamily member 13CDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 4

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
128.3 TPM
Baço
91.7 TPM
Intestino delgado
21.3 TPM
Sangue
7.4 TPM
Skin Sun Exposed Lower leg
4.5 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 4
HGNC:17755UniProt:Q96RJ3
CD40LGCD40 ligandDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathwayImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency with hyper-IgM, type 1

Immunoglobulin isotype switch defect characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. Affected males present at an early age (usually within the first year of life) recurrent bacterial and opportunistic infections, including Pneumocystis carinii pneumonia and intractable diarrhea due to cryptosporidium infection. Despite substitution treatment with intravenous immunoglobulin, the overall prognosis is rather poor, with a death rate of about 10% before adolescence.

OUTRAS DOENÇAS (1)
hyper-IgM syndrome type 1
HGNC:11935UniProt:P29965
CD40Tumor necrosis factor receptor superfamily member 5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathwayImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency with hyper-IgM 3

A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.

OUTRAS DOENÇAS (1)
hyper-IgM syndrome type 3
HGNC:11919UniProt:P25942
PIK3R1Phosphatidylinositol 3-kinase regulatory subunit alphaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerPI3K events in ERBB2 signalingAntigen activates B Cell Receptor (BCR) leading to generation of second messengers
MECANISMO DE DOENÇA

Agammaglobulinemia 7, autosomal recessive

A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
154.4 TPM
Esôfago - Muscular
89.5 TPM
Esôfago - Junção
83.7 TPM
Mama
82.2 TPM
Útero
78.3 TPM
OUTRAS DOENÇAS (4)
SHORT syndromeimmunodeficiency 36 with lymphoproliferationagammaglobulinemia 7, autosomal recessiveautosomal agammaglobulinemia
HGNC:8979UniProt:P27986
STAT6Signal transducer and activator of transcription 6Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
Interleukin-4 and Interleukin-13 signalingDownstream signal transductionSTAT6-mediated induction of chemokines
MECANISMO DE DOENÇA

Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections

An immunologic disorder characterized by severe allergic disease with onset in infancy. Common features are treatment-resistant atopic dermatitis, food allergies, asthma, eosinophilic gastrointestinal disease, and severe episodes of anaphylaxis. Half of the patients present with recurrent skin, respiratory, and viral infections. Clinical laboratory testing is notable for eosinophilia and markedly elevated serum IgE levels.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
219.3 TPM
Cervix Endocervix
215.3 TPM
Baço
213.2 TPM
Cervix Ectocervix
212.7 TPM
Útero
205.9 TPM
OUTRAS DOENÇAS (2)
hyper-IgE syndrome 6, autosomal dominant, with recurrent infectionssolitary fibrous tumor
HGNC:11368UniProt:P42226
UNGUracil-DNA glycosylaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Chromatin modifications during the maternal to zygotic transition (MZT)Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected pyrimidineDisplacement of DNA glycosylase by APEX1
MECANISMO DE DOENÇA

Immunodeficiency with hyper-IgM 5

A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
74.6 TPM
Linfócitos
54.0 TPM
Skin Sun Exposed Lower leg
51.6 TPM
Skin Not Sun Exposed Suprapubic
49.6 TPM
Testículo
48.5 TPM
OUTRAS DOENÇAS (1)
hyper-IgM syndrome type 5
HGNC:12572UniProt:P13051
STAT2Signal transducer and activator of transcription 2Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (7)
Interferon alpha/beta signalingSARS-CoV-2 activates/modulates innate and adaptive immune responsesRegulation of IFNA/IFNB signalingEvasion by RSV of host interferon responsesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Immunodeficiency 44

An autosomal recessive disorder characterized by increased susceptibility to viral infection, resulting in some patients in encephalopathy and infection-associated neurologic decompensation.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
143.8 TPM
Cervix Endocervix
142.4 TPM
Nervo tibial
140.3 TPM
Baço
128.5 TPM
Fibroblastos
113.5 TPM
OUTRAS DOENÇAS (2)
pseudo-TORCH syndrome 3primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
HGNC:11363UniProt:P52630
IRF7Interferon regulatory factor 7Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Interferon gamma signalingInterferon alpha/beta signalingTRAF3-dependent IRF activation pathwayActivation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)TICAM1-dependent activation of IRF3/IRF7
MECANISMO DE DOENÇA

Immunodeficiency 39, susceptibility to viral infections

An autosomal recessive primary immunodeficiency causing severe, life-threatening acute respiratory distress upon infection with certain viruses, mainly H1N1 influenza A, SARS-CoV-2 and RSV.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
200.6 TPM
Sangue
84.8 TPM
Baço
79.2 TPM
Pulmão
48.1 TPM
Tireoide
44.3 TPM
OUTRAS DOENÇAS (1)
immunodeficiency 39
HGNC:6122UniProt:Q92985
CTLA4Cytotoxic T-lymphocyte protein 4Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Co-stimulation by CD28Co-inhibition by CTLA4RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
MECANISMO DE DOENÇA

Systemic lupus erythematosus

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
5.8 TPM
Intestino delgado
4.9 TPM
Pulmão
4.3 TPM
Testículo
2.5 TPM
Sangue
1.8 TPM
OUTRAS DOENÇAS (6)
autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiencysystemic lupus erythematosusgranulomatosis with polyangiitismycosis fungoides
HGNC:2505UniProt:P16410
SP110Sp110 nuclear body proteinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hepatic venoocclusive disease with immunodeficiency

Autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B-cell immunodeficiency, absent lymph node germinal centers, and absent tissue plasma cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
66.4 TPM
Sangue
41.0 TPM
Baço
35.3 TPM
Pulmão
19.7 TPM
Nervo tibial
18.0 TPM
OUTRAS DOENÇAS (2)
hepatic veno-occlusive disease-immunodeficiency syndromeMycobacterium tuberculosis, susceptibility
HGNC:5401UniProt:Q9HB58
UNC13DProtein unc-13 homolog DDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Hemophagocytic lymphohistiocytosis, familial, 3

A rare disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
124.8 TPM
Baço
103.6 TPM
Pulmão
73.5 TPM
Linfócitos
59.8 TPM
Nervo tibial
38.4 TPM
OUTRAS DOENÇAS (2)
familial hemophagocytic lymphohistiocytosis 3hereditary hemophagocytic lymphohistiocytosis
HGNC:23147UniProt:Q70J99
CYBC1Cytochrome b-245 chaperone 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Granulomatous disease, chronic, autosomal recessive, 5

A form of chronic granulomatous disease, a primary immunodeficiency characterized by severe recurrent bacterial and fungal infections, along with manifestations of chronic granulomatous inflammation. It results from an impaired ability of phagocytes to mount a burst of reactive oxygen species in response to pathogens. CGD5 is an autosomal recessive form characterized by onset of recurrent infections and severe colitis in the first decade of life. Clinical manifestations include increased susceptibility to catalase-positive organisms, features of inflammatory bowel disease, lymphopenia, lymphadenitis, and autoinflammatory symptoms in some patients.

OUTRAS DOENÇAS (2)
granulomatous disease, chronic, autosomal recessive, 5chronic granulomatous disease
HGNC:28672UniProt:Q9BQA9
MASP2Mannan-binding lectin serine protease 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Initial triggering of complementLectin pathway of complement activationFicolins bind to repetitive carbohydrate structures on the target cell surfaceSARS-CoV-2 activates/modulates innate and adaptive immune responses
MECANISMO DE DOENÇA

MASP2 deficiency

A disorder that results in autoimmune manifestations, recurrent severe infections, and chronic inflammatory disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
119.6 TPM
Cérebro - Hemisfério cerebelar
18.0 TPM
Cerebelo
17.5 TPM
Nervo tibial
9.6 TPM
Útero
7.7 TPM
OUTRAS DOENÇAS (1)
immunodeficiency due to MASP-2 deficiency
HGNC:6902UniProt:O00187
ITKTyrosine-protein kinase ITK/TSKDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Generation of second messenger moleculesFCERI mediated Ca+2 mobilization
MECANISMO DE DOENÇA

Lymphoproliferative syndrome 1

A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Inadequate immune response to EBV can have a fatal outcome. Clinical features include splenomegaly, lymphadenopathy, anemia, thrombocytopenia, pancytopenia, recurrent infections. There is an increased risk for lymphoma.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
16.6 TPM
Sangue
10.5 TPM
Intestino delgado
10.4 TPM
Pulmão
8.9 TPM
Adipose Visceral Omentum
3.9 TPM
OUTRAS DOENÇAS (1)
lymphoproliferative syndrome 1
HGNC:6171UniProt:Q08881
CD19B-lymphocyte antigen CD19Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersRegulation of Complement cascadeImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 3

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 3
HGNC:1633UniProt:P15391
SEC61A1Protein transport protein Sec61 subunit alpha isoform 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
SRP-dependent cotranslational protein targeting to membrane
MECANISMO DE DOENÇA

Tubulointerstitial kidney disease, autosomal dominant 5

A form of autosomal dominant tubulointerstitial kidney disease, a genetically heterogeneous disorder characterized by slowly progressive loss of kidney function, bland urinary sediment, hyperuricemia, absent or mildly increased albuminuria, lack of severe hypertension during the early stages, and normal or small kidneys on ultrasound. Renal histology shows variable abnormalities including interstitial fibrosis with tubular atrophy, microcystic dilatation of the tubules, thickening of tubular basement membranes, medullary cysts, and secondary glomerulosclerotic or glomerulocystic changes with abnormal glomerular tufting. There is significant variability, as well as incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
395.9 TPM
Pituitária
215.7 TPM
Cervix Endocervix
198.3 TPM
Pâncreas
192.4 TPM
Pulmão
180.5 TPM
OUTRAS DOENÇAS (3)
hyperuricemic nephropathy, familial juvenile type 4immunodeficiency, common variable, 15neutropenia, severe congenital, 11, autosomal dominant
HGNC:18276UniProt:P61619
NFKB1Nuclear factor NF-kappa-B p105 subunitDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
TAK1-dependent IKK and NF-kappa-B activation TRAF6 mediated NF-kB activationRIP-mediated NFkB activation via ZBP1DEx/H-box helicases activate type I IFN and inflammatory cytokines production IkBA variant leads to EDA-ID
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 12, with autoimmunity

A primary immunodeficiency characterized by hypogammaglobulinemia and recurrent bacterial infections. About half of patients develop autoimmune features, including cytopenia, as well as generalized inflammation and lymphoproliferation manifest as lymphadenopathy or hepatosplenomegaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
98.0 TPM
Cervix Ectocervix
35.2 TPM
Pulmão
33.6 TPM
Cervix Endocervix
33.4 TPM
Útero
33.2 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 12
HGNC:7794UniProt:P19838
STAT1Signal transducer and activator of transcription 1-alpha/betaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Interferon alpha/beta signalingSARS-CoV-2 activates/modulates innate and adaptive immune responsesPKR-mediated signalingInterleukin-20 family signalingInterleukin-6 signaling
MECANISMO DE DOENÇA

Immunodeficiency 31B

A disorder characterized by susceptibility to severe mycobacterial and viral infections. Affected individuals can develop disseminated infections and die of viral illness.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
501.4 TPM
Fibroblastos
236.5 TPM
Pulmão
63.5 TPM
Baço
61.7 TPM
Aorta
51.6 TPM
OUTRAS DOENÇAS (3)
immunodeficiency 31Bautoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndromeMendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
HGNC:11362UniProt:P42224
STAT3Signal transducer and activator of transcription 3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Interleukin-20 family signalingDownstream signal transductionInterleukin-15 signalingSignaling by SCF-KITInterleukin-9 signaling
MECANISMO DE DOENÇA

Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections

A rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
173.0 TPM
Artéria tibial
145.7 TPM
Aorta
144.8 TPM
Adipose Visceral Omentum
140.2 TPM
Fallopian Tube
136.9 TPM
OUTRAS DOENÇAS (7)
hyper-IgE recurrent infection syndrome 1, autosomal dominantSTAT3-related early-onset multisystem autoimmune diseasebreast implant-associated anaplastic large cell lymphomaacute promyelocytic leukemia
HGNC:11364UniProt:P40763
STXBP2Syntaxin-binding protein 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Other interleukin signalingPlatelet degranulation
MECANISMO DE DOENÇA

Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease

A rare, autosomal recessive disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia. Some patients may present in early infancy with severe diarrhea, prior to the onset of typical FHL features, whereas others present later in childhood and have a more protracted course without diarrhea. The early-onset diarrhea is due to enteropathy reminiscent of microvillus inclusion disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
274.3 TPM
Baço
123.5 TPM
Testículo
99.9 TPM
Pulmão
94.5 TPM
Glândula salivar
76.0 TPM
OUTRAS DOENÇAS (2)
familial hemophagocytic lymphohistiocytosis 5hereditary hemophagocytic lymphohistiocytosis
HGNC:11445UniProt:Q15833
STX11Syntaxin-11Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hemophagocytic lymphohistiocytosis, familial, 4

A rare disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
57.7 TPM
Pulmão
41.2 TPM
Linfócitos
39.2 TPM
Adipose Visceral Omentum
36.7 TPM
Tecido adiposo
27.1 TPM
OUTRAS DOENÇAS (2)
familial hemophagocytic lymphohistiocytosis 4hereditary hemophagocytic lymphohistiocytosis
HGNC:11429UniProt:O75558
IKBKGNF-kappa-B essential modulatorDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
SARS-CoV-2 activates/modulates innate and adaptive immune responsesNOD1/2 Signaling PathwayTAK1-dependent IKK and NF-kappa-B activation Interleukin-1 signalingJNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
MECANISMO DE DOENÇA

Ectodermal dysplasia and immunodeficiency 1

A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. EDAID1 is an X-linked recessive disorder characterized by absence of sweat glands, sparse scalp hair, rare conical teeth and immunological abnormalities resulting in severe infectious diseases. Severely affected individuals may also show lymphedema, osteopetrosis, and, rarely, hematologic abnormalities. The phenotype is highly variable, and may be fatal in childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
7.4 TPM
Sangue
7.3 TPM
Baço
7.2 TPM
Pulmão
7.0 TPM
Útero
6.7 TPM
OUTRAS DOENÇAS (6)
incontinentia pigmentiectodermal dysplasia and immunodeficiency 1autoinflammatory disease, X-linkedimmunodeficiency 33
HGNC:5961UniProt:Q9Y6K9
IL10RAInterleukin-10 receptor subunit alphaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Interleukin-10 signalingNuclear events stimulated by ALK signaling in cancer
MECANISMO DE DOENÇA

Inflammatory bowel disease 28, autosomal recessive

A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
149.9 TPM
Sangue
69.4 TPM
Pulmão
46.5 TPM
Intestino delgado
41.5 TPM
Linfócitos
30.5 TPM
OUTRAS DOENÇAS (2)
inflammatory bowel disease 28IL10-related early-onset inflammatory bowel disease
HGNC:5964UniProt:Q13651
TNFRSF13BTumor necrosis factor receptor superfamily member 13BDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 2

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
214.4 TPM
Baço
29.6 TPM
Intestino delgado
7.7 TPM
Sangue
1.5 TPM
Cólon transverso
1.4 TPM
OUTRAS DOENÇAS (2)
immunoglobulin A deficiency 2immunodeficiency, common variable, 2
HGNC:18153UniProt:O14836
NFKB2Nuclear factor NF-kappa-B p100 subunitDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
TAK1-dependent IKK and NF-kappa-B activation TRAF6 mediated NF-kB activationRIP-mediated NFkB activation via ZBP1DEx/H-box helicases activate type I IFN and inflammatory cytokines production IkBA variant leads to EDA-ID
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
181.3 TPM
Baço
75.9 TPM
Pulmão
63.1 TPM
Cólon sigmoide
61.8 TPM
Fallopian Tube
53.4 TPM
OUTRAS DOENÇAS (2)
immunodeficiency, common variable, 10deficiency in anterior pituitary function - variable immunodeficiency syndrome
HGNC:7795UniProt:Q00653
ICOSInducible T-cell costimulatorDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Nuclear events stimulated by ALK signaling in cancer
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 1

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Baixa expressão)
Baço
3.4 TPM
Pulmão
2.2 TPM
Intestino delgado
2.1 TPM
Sangue
2.0 TPM
Adipose Visceral Omentum
0.6 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 1
HGNC:5351UniProt:Q9Y6W8
FCN3Ficolin-3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Initial triggering of complementLectin pathway of complement activationFicolins bind to repetitive carbohydrate structures on the target cell surface
MECANISMO DE DOENÇA

Ficolin 3 deficiency

A disorder characterized by immunodeficiency, recurrent infections, brain abscesses and recurrent warts on the fingers. Affected individuals have normal levels of lymphocytes, normal T-cell responses, and normal antibodies, but a selective deficient antibody response to pneumococcal polysaccharide vaccine.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
1136.1 TPM
Fígado
65.8 TPM
Adipose Visceral Omentum
47.8 TPM
Glândula adrenal
37.8 TPM
Rim - Córtex
32.1 TPM
OUTRAS DOENÇAS (1)
immunodeficiency due to ficolin3 deficiency
HGNC:3625UniProt:O75636
MSNMoesinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Recycling pathway of L1Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
MECANISMO DE DOENÇA

Immunodeficiency 50

A primary immunodeficiency disorder characterized by onset of recurrent bacterial or varicella zoster virus infections in early childhood, profound lymphopenia, hypogammaglobulinemia, fluctuating monocytopenia and neutropenia, and a poor immune response to vaccine antigens.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
365.9 TPM
Linfócitos
361.1 TPM
Aorta
345.8 TPM
Artéria tibial
335.1 TPM
Fibroblastos
288.3 TPM
OUTRAS DOENÇAS (1)
combined immunodeficiency due to moesin deficiency
HGNC:7373UniProt:P26038
BCL11BB-cell lymphoma/leukemia 11BDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)Formation of the embryonic stem cell BAF (esBAF) complex
MECANISMO DE DOENÇA

Immunodeficiency 49, severe combined

A form of severe combined immunodeficiency characterized by severe T-cell lymphopenia, no detectable T-cell receptor excision circles, no naive helper CD4+ T-cells, and impaired T-cell proliferative response. In addition to primary immunodeficiency, affected individuals manifest multiple abnormal systemic features, including severe delayed psychomotor development, intellectual disability, spastic quadriplegia, and craniofacial abnormalities.

OUTRAS DOENÇAS (2)
immunodeficiency 49intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities
HGNC:13222UniProt:Q9C0K0
CD27CD27 antigenDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Lymphoproliferative syndrome 2

An autosomal recessive immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia, and impaired T-cell-dependent B-cell responses and T-cell dysfunction. The phenotype is highly variable, ranging from asymptomatic borderline-low hypogammaglobulinemia, to a full-blown symptomatic systemic inflammatory response with life-threatening EBV-related complications, including hemophagocytic lymphohistiocytosis, a lymphoproliferative disorder, and malignant lymphoma requiring stem cell transplantation.

OUTRAS DOENÇAS (1)
lymphoproliferative syndrome 2
HGNC:11922UniProt:P26842
CD81CD81 antigenDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Regulation of Complement cascadeImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 6

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 6
HGNC:1701UniProt:P60033
IKZF1DNA-binding protein IkarosDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
NOTCH3 Intracellular Domain Regulates Transcription
EXPRESSÃO TECIDUAL(Ubíquo)
Baço
34.6 TPM
Sangue
30.1 TPM
Linfócitos
21.4 TPM
Intestino delgado
11.1 TPM
Pulmão
10.5 TPM
OUTRAS DOENÇAS (3)
pancytopenia due to IKZF1 mutationsStevens-Johnson syndromeB-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
HGNC:13176UniProt:Q13422
ATP6AP1V-type proton ATPase subunit S1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transport
MECANISMO DE DOENÇA

Immunodeficiency 47

A complex immunodeficiency syndrome characterized by hypogammaglobulinemia, recurrent bacterial infections, defective glycosylation of serum proteins, and liver disease with neonatal jaundice and hepatosplenomegaly. Some patients may also have neurologic features, including seizures, mild intellectual disability, and behavioral abnormalities. Inheritance is X-linked recessive.

OUTRAS DOENÇAS (1)
immunodeficiency 47
HGNC:868UniProt:Q15904
FCGR3ALow affinity immunoglobulin gamma Fc region receptor III-ADisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
Role of phospholipids in phagocytosisFCGR3A-mediated IL10 synthesisRegulation of actin dynamics for phagocytic cup formationFCGR activationFCGR3A-mediated phagocytosis
MECANISMO DE DOENÇA

Immunodeficiency 20

A rare autosomal recessive primary immunodeficiency characterized by functional deficiency of NK cells. Affected individuals typically present with severe herpes viral infections, particularly Epstein Barr virus (EBV), and human papillomavirus (HPV).

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
240.9 TPM
Sangue
164.2 TPM
Pulmão
76.0 TPM
Aorta
36.0 TPM
Glândula adrenal
32.2 TPM
OUTRAS DOENÇAS (1)
autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity
HGNC:3619UniProt:P08637
PRF1Perforin-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Nuclear events stimulated by ALK signaling in cancer
MECANISMO DE DOENÇA

Hemophagocytic lymphohistiocytosis, familial, 2

A rare disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
119.4 TPM
Baço
84.6 TPM
Pulmão
28.8 TPM
Intestino delgado
8.4 TPM
Adipose Visceral Omentum
7.5 TPM
OUTRAS DOENÇAS (6)
lymphoma, non-Hodgkin, familialfamilial hemophagocytic lymphohistiocytosis 2aplastic anemiahereditary hemophagocytic lymphohistiocytosis
HGNC:9360UniProt:P14222
SMARCAL1SNF2 related chromatin remodeling annealing helicase 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Schimke immuno-osseous dysplasia

An autosomal recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and immunodeficiency. Arteriosclerosis may also occur in some case.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
25.0 TPM
Linfócitos
22.6 TPM
Cervix Ectocervix
20.5 TPM
Ovário
19.9 TPM
Cervix Endocervix
19.8 TPM
OUTRAS DOENÇAS (1)
Schimke immuno-osseous dysplasia
HGNC:11102UniProt:Q9NZC9
SPINK5Serine protease inhibitor Kazal-type 5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
MECANISMO DE DOENÇA

Netherton syndrome

An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
1154.5 TPM
Vagina
666.4 TPM
Skin Sun Exposed Lower leg
328.5 TPM
Skin Not Sun Exposed Suprapubic
312.4 TPM
Glândula salivar
10.8 TPM
OUTRAS DOENÇAS (1)
Netherton syndrome
HGNC:15464UniProt:Q9NQ38
RMRPDisease-causing germline mutation(s) inDesconhecido
OUTRAS DOENÇAS (5)
metaphyseal dysplasia without hypotrichosisanauxetic dysplasia 1cartilage-hair hypoplasiaOmenn syndrome
HGNC:10031

Medicamentos e terapias

MEGESTROL ACETATEPhase 4

Mecanismo: Progesterone receptor agonist

LENIOLISIB PHOSPHATEPhase 4

Mecanismo: PI3-kinase p110-delta subunit inhibitor

INTERFERON GAMMA-1BPhase 4

Mecanismo: Interferon gamma receptor agonist

EMAPALUMABPhase 4

Mecanismo: Interferon gamma inhibitor

ECULIZUMABPhase 4

Mecanismo: Complement C5 inhibitor

IDECABTAGENE VICLEUCELPhase 4

Mecanismo: Tumor necrosis factor receptor superfamily member 17 binding agent

RILONACEPTPhase 4

Mecanismo: Interleukin-1 beta inhibitor

NARSOPLIMABPhase 3

Mecanismo: Mannan-binding lectin serine protease 2 inhibitor

IPTACOPANPhase 3

Mecanismo: Complement factor B inhibitor

LENIOLISIBPhase 3

Mecanismo: PI3-kinase p110-delta subunit inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

280 variantes patogênicas registradas no ClinVar.

🧬 ZNF341: NM_001282933.2(ZNF341):c.1024C>T (p.Arg342Ter) ()
🧬 ZNF341: NM_001282933.2(ZNF341):c.400del (p.Ile134fs) ()
🧬 ZNF341: NM_001282933.2(ZNF341):c.1350C>A (p.Cys450Ter) ()
🧬 ZNF341: NM_001282933.2(ZNF341):c.1253del (p.Gln418fs) ()
🧬 ZNF341: NM_001282933.2(ZNF341):c.720del (p.Met240fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 646 variantes classificadas pelo ClinVar.

65
97
484
Patogênica (10.1%)
VUS (15.0%)
Benigna (74.9%)
VARIANTES MAIS SIGNIFICATIVAS
STAT2: NM_005419.4(STAT2):c.1027C>T (p.Arg343Ter) [Pathogenic]
STAT2: NM_005419.4(STAT2):c.1467del (p.Lys490fs) [Pathogenic]
STAT2: NM_005419.4(STAT2):c.2524A>G (p.Thr842Ala) [Uncertain significance]
STAT2: NM_005419.4(STAT2):c.2164G>C (p.Glu722Gln) [Uncertain significance]
STAT2: NM_005419.4(STAT2):c.1183G>T (p.Gly395Cys) [Uncertain significance]

Vias biológicas (Reactome)

274 vias biológicas associadas aos genes desta condição.

Activation of NF-kappaB in B cells Downstream TCR signaling FCERI mediated NF-kB activation CLEC7A (Dectin-1) signaling Cell surface interactions at the vascular wall CD22 mediated BCR regulation Potential therapeutics for SARS Antigen activates B Cell Receptor (BCR) leading to generation of second messengers Effects of PIP2 hydrolysis Apoptotic cleavage of cellular proteins Caspase activation via Death Receptors in the presence of ligand NOD1/2 Signaling Pathway TRIF-mediated programmed cell death Caspase-mediated cleavage of cytoskeletal proteins Regulation by c-FLIP RIPK1-mediated regulated necrosis CASP8 activity is inhibited TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling CLEC7A/inflammasome pathway Regulation of necroptotic cell death Dimerization of procaspase-8 Activation, myristolyation of BID and translocation to mitochondria Apoptotic execution phase FasL/ CD95L signaling TRAIL signaling TLR3-mediated TICAM1-dependent programmed cell death NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 Microbial modulation of RIPK1-mediated regulated necrosis Defective RIPK1-mediated regulated necrosis Regulation of NF-kappa B signaling TNFs bind their physiological receptors Interferon alpha/beta signaling Regulation of IFNA/IFNB signaling SARS-CoV-2 activates/modulates innate and adaptive immune responses Evasion by RSV of host interferon responses Interleukin-21 signaling RUNX1 regulates transcription of genes involved in differentiation of HSCs Transcriptional regulation of granulopoiesis Interleukin-6 signaling MAPK3 (ERK1) activation MAPK1 (ERK2) activation IL-6-type cytokine receptor ligand interactions Interleukin-35 Signalling Interleukin-27 signaling Golgi Associated Vesicle Biogenesis Signaling by BRAF and RAF1 fusions Terminal pathway of complement Regulation of Complement cascade Initial triggering of complement Classical antibody-mediated complement activation Dengue virus activates/modulates innate and adaptive immune responses Activation of C3 and C5 Miscellaneous transport and binding events Signaling by ERBB2 Downregulation of ERBB2 signaling RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOG GTPase cycle RAC3 GTPase cycle Constitutive Signaling by Overexpressed ERBB2 Drug-mediated inhibition of ERBB2 signaling Signaling by ERBB2 KD Mutants Resistance of ERBB2 KD mutants to trastuzumab Resistance of ERBB2 KD mutants to sapitinib Resistance of ERBB2 KD mutants to tesevatinib Resistance of ERBB2 KD mutants to neratinib Resistance of ERBB2 KD mutants to osimertinib Resistance of ERBB2 KD mutants to afatinib Resistance of ERBB2 KD mutants to AEE788 Resistance of ERBB2 KD mutants to lapatinib Signaling by ERBB2 ECD mutants Signaling by ERBB2 TMD/JMD mutants Drug resistance in ERBB2 TMD/JMD mutants Regulation of signaling by CBL PIP3 activates AKT signaling Synthesis of PIPs at the plasma membrane Constitutive Signaling by Aberrant PI3K in Cancer CD28 dependent PI3K/Akt signaling Interleukin-3, Interleukin-5 and GM-CSF signaling PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling RET signaling Erythropoietin activates Phosphoinositide-3-kinase (PI3K) Interleukin receptor SHC signaling Signaling by CSF1 (M-CSF) in myeloid cells High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Co-stimulation by ICOS Formation of the beta-catenin:TCF transactivating complex Deactivation of the beta-catenin transactivating complex Ca2+ pathway Binding of TCF/LEF:CTNNB1 to target gene promoters Repression of WNT target genes RUNX3 regulates WNT signaling Regulation of MITF-M-dependent genes involved in cell cycle and proliferation Specification of the neural plate border Regulation of PD-L1(CD274) transcription Calmodulin induced events SHC1 events in ERBB2 signaling DAG and IP3 signaling Role of phospholipids in phagocytosis G alpha (z) signalling events HuR (ELAVL1) binds and stabilizes mRNA VEGFR2 mediated cell proliferation RHO GTPases Activate NADPH Oxidases Neutrophil degranulation Interferon gamma signaling KEAP1-NFE2L2 pathway Interleukin-4 and Interleukin-13 signaling Alternative complement activation Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Peptide ligand-binding receptors Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) G alpha (i) signalling events Post-translational protein phosphorylation Purinergic signaling in leishmaniasis infection Common Pathway of Fibrin Clot Formation RIP-mediated NFkB activation via ZBP1 NF-kB is activated and signals survival TAK1-dependent IKK and NF-kappa-B activation SUMOylation of immune response proteins IkBA variant leads to EDA-ID Ub-specific processing proteases Interleukin-1 signaling TRAF6 mediated NF-kB activation SARS-CoV-1 activates/modulates innate immune responses Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Dengue virus modulates apoptosis SLBP independent Processing of Histone Pre-mRNAs RNA Polymerase II Transcription Termination SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs Regulation by TREX1 IRF3-mediated induction of type I IFN Loss of MECP2 binding ability to the NCoR/SMRT complex SUMOylation of transcription cofactors Loss of function of MECP2 in Rett syndrome Regulation of MECP2 expression and activity Transcriptional Regulation by MECP2 Loss of phosphorylation of MECP2 at T308 SUMOylation of transcription factors mRNA decay by 3' to 5' exoribonuclease Association of TriC/CCT with target proteins during biosynthesis Activation of caspases through apoptosome-mediated cleavage SMAC (DIABLO) binds to IAPs SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes SMAC, XIAP-regulated apoptotic response TNFR1-induced NF-kappa-B signaling pathway Regulation of PTEN localization Regulation of PTEN stability and activity Regulation of the apoptosome activity ROS and RNS production in phagocytes Cross-presentation of particulate exogenous antigens (phagosomes) Detoxification of Reactive Oxygen Species VEGFA-VEGFR2 Pathway Defective B3GALTL causes PpS O-glycosylation of TSR domain-containing proteins FCGR activation Regulation of actin dynamics for phagocytic cup formation Scavenging of heme from plasma Fc epsilon receptor (FCERI) signaling Role of LAT2/NTAL/LAB on calcium mobilization FCERI mediated MAPK activation FCERI mediated Ca+2 mobilization FCGR3A-mediated IL10 synthesis FCGR3A-mediated phagocytosis TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway PI3K Cascade IRS-mediated signalling GPVI-mediated activation cascade Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants PI3K events in ERBB4 signaling Interleukin-7 signaling Signaling by SCF-KIT GAB1 signalosome Signaling by cytosolic FGFR1 fusion mutants Downstream signal transduction PI3K events in ERBB2 signaling PI3K/AKT activation Signaling by ALK Tie2 Signaling DAP12 signaling Nephrin family interactions G alpha (q) signalling events GP1b-IX-V activation signalling Constitutive Signaling by EGFRvIII PI-3K cascade:FGFR1 PI-3K cascade:FGFR2 STAT6-mediated induction of chemokines Recognition and association of DNA glycosylase with site containing an affected pyrimidine Cleavage of the damaged pyrimidine Displacement of DNA glycosylase by APEX1 Chromatin modifications during the maternal to zygotic transition (MZT) Interleukin-20 family signaling DEx/H-box helicases activate type I IFN and inflammatory cytokines production TICAM1-dependent activation of IRF3/IRF7 TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling Co-stimulation by CD28 Co-inhibition by CTLA4 RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) Lectin pathway of complement activation Ficolins bind to repetitive carbohydrate structures on the target cell surface Generation of second messenger molecules ER-Phagosome pathway SRP-dependent cotranslational protein targeting to membrane Regulated proteolysis of p75NTR Senescence-Associated Secretory Phenotype (SASP) PKMTs methylate histone lysines Transcriptional regulation of white adipocyte differentiation Interleukin-1 processing CD209 (DC-SIGN) signaling MAP3K8 (TPL2)-dependent MAPK1/3 activation The NLRP3 inflammasome Transcriptional Regulation by VENTX HCMV Early Events Regulation of NFE2L2 gene expression ISG15 antiviral mechanism Downregulation of SMAD2/3:SMAD4 transcriptional activity Regulation of IFNG signaling Regulation of RUNX2 expression and activity Interleukin-9 signaling NOTCH3 Intracellular Domain Regulates Transcription Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants Signaling by PDGFRA extracellular domain mutants Signaling by CSF3 (G-CSF) Inactivation of CSF3 (G-CSF) signaling Signaling by ALK fusions and activated point mutants Growth hormone receptor signaling PKR-mediated signaling BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members Signalling to STAT3 Signaling by Leptin POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation Transcriptional regulation of pluripotent stem cells Interleukin-10 signaling PTK6 Activates STAT3 MET activates STAT3 Interleukin-15 signaling Interleukin-37 signaling Interleukin-23 signaling Platelet degranulation Other interleukin signaling Disinhibition of SNARE formation TICAM1, RIP1-mediated IKK complex recruitment activated TAK1 mediates p38 MAPK activation JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 IKBKB deficiency causes SCID IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) Ovarian tumor domain proteases IRAK1 recruits IKK complex IKK complex recruitment mediated by RIP1 IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation SLC15A4:TASL-dependent IRF5 activation Nuclear events stimulated by ALK signaling in cancer Dectin-1 mediated noncanonical NF-kB signaling NIK-->noncanonical NF-kB signaling Recycling pathway of L1 Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea Formation of the embryonic stem cell BAF (esBAF) complex Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) Insulin receptor recycling Transferrin endocytosis and recycling Ion channel transport Defective Inhibition of DNA Recombination at Telomere Formation of the cornified envelope Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado19
3Fase 333
2Fase 215
1Fase 14
·Pré-clínico39
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 100 ensaios
✓ Aprovados — podem ser usados hoje
MEGESTROL ACETATELENIOLISIB PHOSPHATEINTERFERON GAMMA-1BEMAPALUMABECULIZUMABIDECABTAGENE VICLEUCELRILONACEPT
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Imunodeficiência primária

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 10 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

21 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT07698197 · Exercise Intervention and ImmunodeficiencyRecrutando
NA🇺🇸 Estados Unidos
NCT06519734 · Primitive Immunodeficiency, Intrauterine Devices and Menstru…Recrutando
🇫🇷 França
NCT06669949 · Natural History of Sphingosine Phosphate Lyase Insufficiency…Recrutando
🇺🇸 Estados Unidos
NCT06565078 · A Database Survey to Evaluate the Safety of Immune Globulin …Recrutando
🇯🇵 Japão
NCT07261891 · Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical A…Recrutando
NA🇧🇪 Bélgica
NCT06169150 · Detection and Characterization of Neurologic Manifestations …Recrutando
🇺🇸 Estados Unidos
NCT05189925 · NADPH Oxidase Correction in mRNA-transfected Granulocyte-enr…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT04691622 · Adoptive T Lymphocyte Administration for Chronic Norovirus T…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT04784364 · Biologics And Clinical Immunology Cohort at SinaiRecrutando
🇺🇸 Estados Unidos
NCT04528355 · Data Collection Study of Patients With Non-Malignant Disorde…Recrutando
🇺🇸 Estados Unidos
NCT03266653 · EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory E…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT04197596 · Treatment of Refractory BK Infections With Related Donor BK …Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT04459689 · COVID-19 in PID SurveyRecrutando
🇫🇷 França
NCT03266627 · Adenovirus-specific Cytotoxic T-lymphocytes for Refractory A…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT03394053 · The Mechanistic Biology of Primary Immunodeficiency Disorder…Recrutando
🇺🇸 Estados Unidos
NCT03206099 · NIAID Centralized Sequencing ProtocolRecrutando
🇺🇸 Estados Unidos
NCT02735824 · Genetic Study of Immunodeficiency: Search for New Genetic Ca…Recrutando
🇨🇭 Suíça
NCT01962415 · Reduced Intensity Conditioning for Non-Malignant Disorders U…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT01222741 · Studies of Disorders With Increased Susceptibility to Fungal…Recrutando
🇺🇸 Estados Unidos
NCT00246857 · Screening Protocol for Genetic Diseases of Lymphocyte Homeos…Recrutando
Turkey (Türkiye) · 🇺🇸 Estados Unidos
NCT00895271 · Establishing Fibroblast-Derived Cell Lines From Skin Biopsie…Por convite
🇺🇸 Estados Unidos

Outros ensaios clínicos

134 ensaios clínicos encontrados, 38 ativos.

Distribuição por fase
NCT07794735 · A Study of TAK-664 in People With Primary Immunodeficiency D…Em breve
PHASE4
NCT07873970 · 25BT056: Basket Study of Viral Cytotoxic T LymphocytesEm breve
EARLY_PHASE1
NCT07837518 · Knowledge of Inborn Errors of Immunity Among Pediatric Physi…Em breve
NCT07697118 · Study Evaluating a Gene Therapy for IPEX Syndrome Through th…Em breve
PHASE1, PHASE2🇫🇷 França
NCT06150833 · IVIG Boya: Safety, Efficacy, and PharmacokineticsEm breve
PHASE3
NCT07526714 · Longitudinal Prognosis of Lymphoproliferative Manifestations…Em breve
NCT07262047 · Quality of Life Among Children With Inborn Error of ImmunityEm breve
NCT07017036 · Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID …Em breve
PHASE3🇮🇳 Índia
NCT06649643 · Inbon Errors of Immunity Attending Assiut University Childre…Em breve
NCT06076642 · A Study About the Long-Term Safety of TAK-881 in People With…Ativo
PHASE3🇨🇿 Tchéquia · 🇩🇰 Dinamarca · Greece +4
NCT05236764 · Haploidentical Hematopoietic Cell Transplantation Using TCR …Ativo
NA🇺🇸 Estados Unidos
NCT04354129 · Observational Study of Subcutaneous Immunoglobulin (Cutaquig…Ativo
🇨🇦 Canadá
NCT04640142 · Study to Evaluate the Pharmacokinetics, Efficacy, Tolerabili…Ativo
PHASE3🇩🇪 Alemanha · Hungary · 🇮🇹 Itália +4
NCT04554914 · A Study to Evaluate Tabelecleucel in Participants With Epste…Ativo
PHASE2🇦🇹 Áustria · 🇧🇪 Bélgica · 🇫🇷 França +4
NCT04565015 · Study of Immune Globulin Intravenous (Human) GC5107 in Pedia…Ativo
PHASE3Bosnia and Herzegovina · Serbia · 🇺🇸 Estados Unidos
NCT03475212 · Antiviral Cellular Therapy for Enhancing T-cell Reconstituti…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT01966367 · CD34+ (Non-Malignant) Stem Cell Selection for Patients Recei…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06549114 · Leniolisib for Immune Dysregulation in PIDsConcluído
PHASE2🇺🇸 Estados Unidos
NCT05758506 · Developing a Screening Tool for Primary Immunodeficiency Dis…Concluído
Pakistan
NCT05621876 · Evaluation of an IgG Deficiency Rapid Screening Test: A Perf…Concluído
Tunisia
NCT05755035 · A Study About How TAK-881 is Processed by the Body and Side …Concluído
PHASE2, PHASE3🇨🇿 Tchéquia · 🇩🇰 Dinamarca · 🇩🇪 Alemanha +5
NCT06014463 · Evaluation of Adult Patients With Immunodeficiency Within th…Concluído
Turkey (Türkiye)
NCT05513586 · A Study to Evaluate the Long-term Safety of TAK-771 in Japan…Concluído
PHASE3🇯🇵 Japão
NCT04919018 · Characterizing the Upper Airway Manifestations in Primary Ci…Concluído
🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT04842643 · An Extension Study of TAK-664 for Japanese People With Prima…Concluído
PHASE3🇯🇵 Japão
NCT05040256 · Neurologic and Immunologic Characteristics of CTLA-4 and LRB…Concluído
🇫🇷 França
NCT04702243 · Defining the Genetic Etiology of Suppurative Lung Disease in…Concluído
🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT04566692 · A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Ex…Concluído
PHASE4🇺🇸 Estados Unidos
NCT04561115 · A Study to Evaluate the Pharmacokinetics, Safety, and Tolera…Concluído
PHASE3🇺🇸 Estados Unidos
NCT03939533 · Study to Monitor Subcutaneous Human Immunoglobulin Administe…Concluído
PHASE3🇺🇸 Estados Unidos
NCT03961009 · Clinical Assessment of Pharmacokinetics, Efficacy, and Safet…Concluído
PHASE3🇺🇸 Estados Unidos
NCT03716700 · Real-world CANadian CUvitru Non-Interventional Study in Subj…Concluído
🇨🇦 Canadá
NCT03618147 · Primary Immunodeficiency in KuwaitConcluído
Kuwait
NCT03427593 · Severe PID With Lymphoproliferation and NeutropeniaConcluído
NA🇫🇷 França
NCT03383380 · Rapamycin Treatment for Activated Phosphoinositide 3-Kinase …Concluído
PHASE1, PHASE2🇨🇳 China
NCT03238079 · Study of PlasmaCap IG in Adults and Children With PIDDConcluído
PHASE3🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT03116347 · Post-Authorization Safety, Tolerability and Immunogenicity E…Concluído
PHASE4🇨🇿 Tchéquia · 🇩🇰 Dinamarca · 🇫🇷 França +5
NCT03033745 · Safety and Tolerability of Higher Infusion Parameters of IgP…Concluído
PHASE4🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT03815357 · What is the Incidence of an Immune Disorder in Children With…Concluído
🇦🇺 Austrália · New Zealand
NCT02881437 · IgG Level in Primary Immunodeficiency Switching From Standar…Concluído
PHASE4🇫🇷 França
NCT03414528 · Identification of New Inborn Errors of ImmunityConcluído
🇨🇭 Suíça
NCT02496676 · Magnesium Supplementation in People With XMEN SyndromeConcluído
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT02711228 · Study of Immune Deficiency Patients Treated With Subcutaneou…Concluído
PHASE4🇨🇦 Canadá
NCT03907241 · CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY…Concluído
PHASE3🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT02269163 · Study of ProMetic BioTherapeutics Immune Globulin Intravenou…Concluído
PHASE3🇺🇸 Estados Unidos
NCT02604810 · Safety and Pharmacokinetics of IGSC 20% in Subjects With Pri…Concluído
PHASE3🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT02503293 · A Study to Compare Quality of Life and Satisfaction in Prima…Concluído
PHASE4🇦🇺 Austrália · 🇩🇪 Alemanha · 🇮🇹 Itália +1
NCT03339778 · The Benefit of 5% IVIG for Patients With Primary Immunodefic…Concluído
NCT02909244 · Study of Gut Microbiota in Primary Immune Deficiency, Possib…Concluído
🇫🇷 França
NCT02888535 · Intensive Care Unit and Secondary and Primary Immune Deficie…Concluído
🇫🇷 França
NCT02180763 · Gammanorm Quality of Life Study in Immunodeficient Patients …Concluído
PHASE4🇫🇷 França
NCT01888484 · Study of Octanorm Subcutaneous IG in Patients With PIDConcluído
PHASE3🇨🇦 Canadá · 🇨🇿 Tchéquia · Hungary +4
NCT01814800 · Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV…Concluído
PHASE3🇺🇸 Estados Unidos
NCT01963143 · Bioequivalence Study to Evaluate the Pharmacokinetics, Safet…Concluído
PHASE3Hungary · 🇬🇧 Reino Unido · 🇺🇸 Estados Unidos
NCT01985373 · Pharmacokinetics and Safety of IVIG Nanogam 100 mg/mlConcluído
PHASE3🇳🇱 Países Baixos
NCT01953016 · Participation in a Research Registry for Immune DisordersConcluído
🇺🇸 Estados Unidos
NCT01859754 · Octagam 5% Versus Comparator Post Marketing TrialConcluído
🇺🇸 Estados Unidos
NCT01218438 · Phase 2/3 Study of IGSC, 20% in PIDDConcluído
PHASE2, PHASE3🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT02327351 · TCR Alpha/Beta Depletion for HSCT From Haploidentical and Un…Concluído
PHASE2, PHASE3Russia
NCT01485796 · Tolerability and Safety of IGI, 10% With rHuPH20 in PIDDConcluído
PHASE2, PHASE3🇺🇸 Estados Unidos
NCT01465958 · Pharmacokinetics, Safety, and Tolerability of Subcutaneous G…Concluído
PHASE4🇺🇸 Estados Unidos
NCT01458171 · Follow-up Study of Subcutaneous Immune Globulin in Patients …Concluído
PHASE3🇯🇵 Japão
NCT01347242 · Gene Therapy for Wiskott-Aldrich Syndrome (WAS)Concluído
PHASE1, PHASE2🇬🇧 Reino Unido
NCT01289847 · A Study to Find Out How Safe and Effective Gammaplex® is in …Concluído
PHASE4🇨🇱 Chile · 🇮🇱 Israel · 🇺🇸 Estados Unidos
NCT01175213 · Tolerability and Safety of Immune Globulin Subcutaneous Solu…Concluído
PHASE3🇺🇸 Estados Unidos
NCT01287689 · Assessment of Immunoglobulins (IgG) in a Long-term Non-inter…Concluído
🇩🇪 Alemanha
NCT01166074 · Retrospective Chart Review of Subcutaneous IgG Use in Infant…Concluído
🇺🇸 Estados Unidos
NCT01131858 · Study of Vitamin D3 Substitution to Patients With Primary Im…Concluído
PHASE1, PHASE2🇸🇪 Suécia
NCT01012323 · A Study of NewGam, Human Immunoglobulin 10%, in Patients Wit…Concluído
PHASE3🇺🇸 Estados Unidos
NCT00919503 · Treosulfan and Fludarabine Phosphate Before Donor Stem Cell …Concluído
PHASE2🇺🇸 Estados Unidos
NCT00774358 · Interleukin-2 Treatment for Wiskott-Aldrich SyndromeConcluído
PHASE1🇺🇸 Estados Unidos
NCT00751621 · Study of Subcutaneous Immune Globulin in Patients Requiring …Concluído
PHASE3🇫🇷 França · 🇩🇪 Alemanha · 🇵🇱 Polônia +5
NCT00719680 · Extension Study of Subcutaneous Immunoglobulin Human in Pati…Concluído
PHASE3🇺🇸 Estados Unidos
NCT00634569 · Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pedia…Concluído
PHASE4🇺🇸 Estados Unidos
NCT00546871 · Comparison of Intravenous and Subcutaneous Administration of…Concluído
PHASE2, PHASE3🇺🇸 Estados Unidos
NCT00405184 · Ig NextGen 10% in Patients With Primary Immune Deficiency (P…Concluído
PHASE3🇦🇺 Austrália
NCT00520494 · Efficacy and Safety of Vivaglobin® in Previously Untreated P…Concluído
PHASE4🇨🇦 Canadá · 🇩🇪 Alemanha · 🇮🇹 Itália +1
NCT00782106 · Study to Determine the Dose of Recombinant Human Hyaluronida…Concluído
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT00278954 · Efficacy, Safety and Pharmacokinetics of Gammaplex in Primar…Concluído
PHASE3🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
4.008 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 4.008

#1

Diagnostic and therapeutic journey of infantile endobronchial tuberculosis: a case report.

Frontiers in pediatrics2026

Endobronchial tuberculosis (EBTB) in infants is rare and is often overlooked because of nonspecific clinical manifestations. Coexisting primary immunodeficiency and opportunistic infections further increased diagnostic and therapeutic complexity. We reported a male infant aged 40 days who presented with fever and mild cough. Chest imaging showed progressive bilateral nodular and granulomatous lesions despite broad-spectrum antibacterial therapy. Microbiological evaluation revealed positive T-SPOT.TB and GeneXpert MTB/RIF results from bronchoalveolar lavage fluid (BALF), while metagenomic next-generation sequencing identified Pneumocystis jirovecii. Genetic testing demonstrated a heterozygous IKZF1 mutation, consistent with underlying immunodeficiency. Serial bronchoscopies confirmed necrotizing endobronchial tuberculosis with airway stenosis. The patient received standard anti-tuberculosis therapy, systemic corticosteroids, trimethoprim-sulfamethoxazole, intravenous immunoglobulin, and repeated bronchoscopic intraluminal drug delivery. Clinical and radiological remission was achieved, with no airway sequelae during 18-month follow-up. This case highlighted the unique coexistence of infantile EBTB, IKZF1-related immunodeficiency, and P. jirovecii coinfection. Early bronchoscopy played a pivotal diagnostic and therapeutic role. Repeated intraluminal bronchoscopic therapy combined with systemic treatment might prevent irreversible airway damage in severe pediatric EBTB.

#2

Expanding the phenotypic and immunological landscape of Alazami syndrome: Evidence from seven new patients with LARP7 gene variants.

European journal of pediatrics2026 Mar 11

Alazami syndrome is a neurodevelopmental disorder characterized by postnatal growth retardation, moderate to severe intellectual disability, and facial dysmorphology. It is caused by biallelic variants in the transcriptional regulator La ribonucleoprotein 7 (LARP7), where frameshift variants accounted for the majority of cases. The current study presents 7 new patients, including 3 males and 4 females from 3 unrelated families. Careful and thorough clinical examination identified novel oro-dental disease abnormalities, including a prominent premaxilla and enamel defects. The detected variants (c.1113_1116del, c.997 + 2T > C and c.518T > C) were not reported in the previous studies. The substitution c.518T > C represented the second missense variant to be identified in patients with Alazami syndrome. Male patients from the three families fulfilled ≥ 2 clinical warning signs of primary immunodeficiency. Lymphocyte subset counts and immunoglobulin levels were estimated in patients from two families. The values were within reference ranges, with only minor non-significant alterations in cytotoxic T-cell counts. A functional assay of B lymphocyte response was performed in one family, demonstrating impaired Streptococcus pneumoniae IgG antibody production following Pneumovax vaccination in the male patient, while his female sibling mounted an adequate response. In conclusion, the disease has a wide range of symptoms, which vary greatly among the affected patients. Our study expanded the clinical and molecular spectrum of the disorder and highlighted immunodeficiency as an underrecognized disease feature, potentially with a male sex predilection.

#3

Genetic analysis of children with suspected immunodeficiency: mimickers of inborn errors of immunity.

European journal of pediatrics2026 Mar 05

Inborn errors of immunity (IEI) comprise a heterogeneous group of disorders with diverse clinical manifestations. In this study, we aimed to evaluate genetic findings in patients with suspected IEI and to assess the contribution of next-generation sequencing (NGS) in identifying both IEI-related and non-IEI-related genetic variants. Between January 2020 and January 2025, 91 pediatric patients (0-18 years) referred for suspected IEI were retrospectively analyzed. Demographic data, clinical features, immunological profiles, and genetic results were reviewed, including single-gene sequencing, fluorescence in situ hybridization (FISH), targeted gene panels (TGP), and whole-exome sequencing (WES). Patients analyzed by NGS were classified into three categories according to detected variants: IEI-related, non-IEI-related, and undetected disease-causing variant. A total of 79 patients underwent NGS-based genetic testing. The mean age was 4.37 ± 5.09 years. WES was performed in 40 patients (50.6%) and TGP in 39 (49.4%). Pathogenic variants linked to IEI-related were detected in 28 patients (35.4%), whereas non-IEI-related pathogenic variants were identified in 12 (15.2%). The remaining 39 patients (49.4%) had undetected disease-causing variants. The diagnoses of patients carrying pathogenic variants unrelated to IEI included primary ciliary dyskinesia, Ellis-van Creveld syndrome, desmoglein-1 deficiency, and others. Conclusion: Our study highlights the importance of genetic testing in the differential diagnosis of IEI and provides evidence supporting its role in identifying mixed IEI phenotypes. Comprehensive interpretation of genetic results within a multidisciplinary clinical framework is essential for accurate diagnosis, appropriate management, and effective genetic counseling.

#4

Familial cartilage-hair hypoplasia: prenatal ultrasound features and clinical outcomes in three siblings with identical RMRP variants.

BMJ case reports2026 Feb 20

Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive skeletal dysplasia. It is often associated with short stature, metaphyseal abnormalities, hair hypoplasia and immune dysfunction. This case describes a pregnant woman in her mid-30s with two previous children diagnosed with CHH with molecular confirmation of two pathogenic variants of the ribonuclease mitochondrial RNA processing gene. The couple is healthy and non-consanguineous. Routine ultrasound examination of the current pregnancy suggested this fetus was also likely to be affected. The couple opted not to perform invasive prenatal diagnosis. Umbilical cord blood was collected at birth for genetic testing, confirming the diagnosis. CHH has a significant impact on the quality of life of those affected. Genetic counselling may help parents understand the disease and its prognosis. Obstetric ultrasound plays an important role in the diagnosis by allowing early detection of suspected cases as well as assessing fetal growth.

#5

Diagnostic yield and clinical impact of genetic testing in inborn errors of immunity: lessons from a large Turkish cohort.

European journal of pediatrics2026 Feb 20

Inborn errors of immunity (IEI) are inherited disorders with heterogeneous clinical, immunological, and genetic features; genetic testing is now indispensable for accurate diagnosis and treatment planning. This study aimed to evaluate the diagnostic yield, inheritance patterns, and clinical impact of genetic testing on IEIs at a tertiary care center in Turkey over a 10-year period. This retrospective cohort included 1407 patients diagnosed with or followed for IEI between 2010 and 2020 at Ankara University Faculty of Medicine. Clinical, immunologic, and molecular data were analyzed to assess subgroup distribution, genetic testing methods, turnaround times, and the influence of genetic results on diagnosis and treatment. Predominantly antibody deficiencies were the most common IEI subgroup (67.8%), followed by combined T- and B-cell immunodeficiencies (12.2%). Parental consanguinity was present in 32.1% of patients. Genetic testing was performed in 417 patients (29.6%), and pathogenic variants were identified in 325 (77.9% of the tested population), involving 94 different genes. Most variants exhibited autosomal recessive inheritance (71.4%). The diagnostic yield was 66.8% for targeted gene panels and 68.4% for whole-exome sequencing. Turnaround times markedly decreased from 28.1 months in 2010 to 2.3 months in 2020. Genetic findings led to diagnostic or therapeutic modifications in 20.6% of patients, primarily through disease reclassification or personalized treatment adjustments. Comprehensive clinical and immunological evaluations remain fundamental to accurate genotypic characterization of patients with IEI. To ensure timely and precise diagnosis, genetic analyses should be initiated early and conducted through close collaboration between clinical immunologists and genetic specialists. • Inborn errors of immunity are clinically and genetically heterogeneous disorders that often require molecular confirmation for accurate diagnosis. • Genetic testing supports individualized management when integrated with detailed clinical and immunological evaluation. • In this 10-year, large national cohort from Turkey, clinically guided genetic testing achieved a high diagnostic yield and identified pathogenic variants in the majority of tested patients. • Genetic results led to diagnostic or therapeutic modifications in approximately one-fifth of cases, emphasizing the importance of early, coordinated collaboration between clinical immunologists and genetic specialists.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.632 artigos no totalmostrando 196

2026

Probiotic improves respiratory and gastrointestinal health, immune homeostasis, and gut microbiota composition in infants: a randomized controlled trial.

Frontiers in nutrition
2026

Diagnostic and therapeutic journey of infantile endobronchial tuberculosis: a case report.

Frontiers in pediatrics
2026

Beyond the Usual Suspects: Gastrointestinal Histoplasmosis as a Marker of Undiagnosed Common Variable Immunodeficiency.

ACG case reports journal
2026

Enhancing Clinical Workflow Efficiency in Flow Cytometry Reporting with LLMs.

Journal of clinical immunology
2026

Cellular signatures of immune dysregulation in inborn errors of immunity: development of a quantitative immune balance score.

Frontiers in immunology
2026

Unveiling a novel NBAS mutation in common variable immunodeficiency: Expanding the genetic landscape of immunodeficiency disorders.

Immunobiology
2026

Impaired mucosal IgA response to SARS-CoV-2 in patients with inborn errors of immunity.

Frontiers in immunology
2026

Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.

Frontiers in immunology
2026

Case Report: a 28-year-old female patient presented with recurrent fevers and episodes of shock due to ZBTB24 pathogenic variant.

Frontiers in immunology
2026

Exploring the strengths and limitations of AI-driven variant prioritization versus manual curation in inborn errors of immunity.

Frontiers in genetics
2026

Primary and Steroid-Induced Antibody Deficiency in Severe Asthma: A Real-Life Analysis of a Well-Defined Biologic-Treated Cohort.

The Journal of asthma : official journal of the Association for the Care of Asthma
2026

Comparison of clinical characteristics in primary immunodeficiency patients based on the presence of autoimmunity or autoinflammation.

Allergy and asthma proceedings
2026

Adaptive multi-stage paramedian forehead flap for nasal reconstruction following HSV-related necrosis in a pediatric patient with primary immunodeficiency.

Case reports in plastic surgery &amp; hand surgery
2026

Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report.

Journal of medical case reports
2025

Bibliometrics of scientific biomedical publications on Primary Immunodeficiency Diseases in the Arab World (2020-2024).

La Tunisie medicale
2026

Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program.

Journal of clinical immunology
2026

The clinical characteristics and outcomes of Campylobacter spp. bloodstream infection: A systematic review and meta-analysis.

European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology
2026

Expanding the phenotypic and immunological landscape of Alazami syndrome: Evidence from seven new patients with LARP7 gene variants.

European journal of pediatrics
2026

Skin involvement is among the leading findings in children with inborn errors of immunity.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2026

Clinico-virological investigation of measles complications in immunocompromised pediatric patients.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2026

Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

Expert review of clinical immunology
2026

Genetic analysis of children with suspected immunodeficiency: mimickers of inborn errors of immunity.

European journal of pediatrics
2025

Griscelli Syndrome in Two Siblings with Silvery Hair: A Case Report.

JNMA; journal of the Nepal Medical Association
2026

Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.

Frontiers in immunology
2026

Plain language summary: Headache and migraine experiences in people with primary immunodeficiency receiving GAMMAPLEX® 5% or 10% intravenous immunoglobulin therapy.

Immunotherapy
2026

Invasive Pulmonary Aspergillosis in a Young Adult With Hyperimmunoglobulin E Syndrome and Hypogammaglobulinemia Following Rituximab Therapy.

Cureus
2026

Persistent eosinophilia following treatment for pediatric pyogenic liver abscess: A case report.

SAGE open medical case reports
2026

Neutrophil hyperresponsiveness contributes to lung pathology in STAT3V463Δ mice.

Journal of immunology (Baltimore, Md. : 1950)
2026

Primary Care Physicians' Perspectives on Primary Immunodeficiency Diseases (Inborn Errors of Immunity).

International archives of allergy and immunology
2026

A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.

Immunity, inflammation and disease
2026

The Relationship Between Peripheral Eosinophilia, Lower Respiratory Tract Pathogens, Age at First Pneumonia, and Malnutrition in Children with Non-cystic Fibrosis Bronchiectasis.

Thoracic research and practice
2026

Genetic Diversity and Excretion Kinetics of Enteroviruses Excreted by Patients with Primary Immunodeficiency in Tunisia over a Five-Year Period (2020-2024).

Microorganisms
2026

The Immunological Role of Vitamin D in Primary Immunodeficiencies: A Narrative Review of the Current Literature.

Biomedicines
2026

Primary Immunodeficiency Diseases with BCG-Induced Diseases: A 15-Year Longitudinal Cohort Study.

Journal of clinical immunology
2026

Distinct pulmonary pathophysiological mechanisms in COPD, bronchiectasis, and primary immunodeficiency: a multi-omics investigation of disease heterogeneity via sputum and blood profiling.

Respiratory research
2026

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2026

Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey.

Immunity, inflammation and disease
2026

Association of maternal immunoglobulin G levels with pregnancy outcomes in primary immunodeficiency: A retrospective single-center study.

Medicine
2025

Opinion: Why paediatric rheumatologists need to understand inborn errors of immunity.

Frontiers in pediatrics
2026

First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.

Frontiers in immunology
2025

Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders.

Canadian liver journal
2026

Familial cartilage-hair hypoplasia: prenatal ultrasound features and clinical outcomes in three siblings with identical RMRP variants.

BMJ case reports
2026

Allergic airway reactions rewired by PI3Kδ mutation.

The Journal of experimental medicine
2026

Diagnostic yield and clinical impact of genetic testing in inborn errors of immunity: lessons from a large Turkish cohort.

European journal of pediatrics
2026

Clinical Characteristics of Children Diagnosed with Food Allergy at Ankara University.

International archives of allergy and immunology
2026

Disseminated Phaeohyphomycosis in a Patient With CARD 9 Mutation.

International journal of dermatology
2026

Clinical and genetic spectrum of inborn errors of immunity: a retrospective study on outcomes at a single center.

Frontiers in immunology
2025

Risk model based on neutrophil-related genes constructs to assess prognosis and immune landscape in sepsis.

Shock (Augusta, Ga.)
2026

DOCK8 deficiency presenting with sclerosing cholangitis, raised immunoglobulin E, and bronchiectasis: A fatal pediatric case report.

JPGN reports
2025

Gene therapy for inborn errors of immunity: past progress, current status and future directions.

Rare disease and orphan drugs journal
2026

Malignancies in the context of Inborn errors of immunity: an immunologist's view.

Expert review of clinical immunology
2026

Expanding Phenotype of GINS1 Deficiency: A Case Report and Review of the Literature.

Clinical genetics
2026

Infection Complications in Pediatric Patients With Inborn Errors of Immunity After Umbilical Cord Blood Transplantation: A Chinese Single-Center Study.

Transplant infectious disease : an official journal of the Transplantation Society
2026

Spectrum of Primary Immune Regulatory Disorders in Children in a Highly Consanguineous Population: Report from a National Registry.

Journal of clinical immunology
2026

Genomic Dissection of Pediatric Protein-Losing Enteropathy and Related Disorders: Clinical, Immunologic, and Therapeutic Insights.

Gastroenterology
2026

Pharmacokinetics, safety and tolerability, and efficacy of hyaluronidase-facilitated subcutaneous immunoglobulin 10% (HyQvia®) in Japanese patients with primary immunodeficiency diseases.

Immunological medicine
2026

Liver Disease in Common Variable Immunodeficiency: Current Evidence and Knowledge Gaps.

International journal of molecular sciences
2026

Immunopathology of immune thrombocytopenia.

Journal of thrombosis and haemostasis : JTH
2026

Smoking Behavior Is Associated With an Altered Immune Landscape in Prostate Cancer: Implications for Patient Outcomes.

The Prostate
2026

Research Progress on Chronic Granulomatous Disease in Children.

Cureus
2026

STAT3-Mutated Hyper-IgE Syndrome With Retroperitoneal Abscess in Adolescence.

Clinical case reports
2026

Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy-Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case Report.

Clinical case reports
2026

Targeted deep sequencing identifies mosaicism in patients with immune dysregulation.

The Journal of allergy and clinical immunology
2026

Metagenomic next-generation sequencing to detect Pneumocystis jirovecii pneumonia in critically ill, HIV-negative children: a retrospective multicenter study.

BMC pulmonary medicine
2025

Epigenetic disruption meets immune deficiency: a case report of ICF syndrome linked to DNMT3B mutation.

Frontiers in immunology
2025

Adverse reactions to intravenous immunoglobulin in primary immunodeficiency: a retrospective analysis.

Postepy dermatologii i alergologii
2025

[Van Wyk-Grombach syndrome as a result of late diagnosis of autoimmune thyroiditis (ait) in a patient with chromosome 22 deletion syndrome. Description of the clinical case and a brief review of the literature].

Problemy endokrinologii
2026

Neutrophil progenitor cell therapy rescues host defense against Staphylococcus aureus in murine chronic granulomatous disease.

Journal of leukocyte biology
2026

WHIM syndrome in a child without the classic tetrad: a case confirmed by de novo CXCR4 mutation.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2026

VP1 molecular evolution of type 2 immunodeficiency-related vaccine-derived polioviruses (iVDPV2) in a patient with primary immunodeficiency disease (PID).

Virus genes
2026

Genetic and epidemiological patterns of primary immunodeficiency diseases in Eastern Iranian patients.

Scientific reports
2026

[STAT1 gain-of-function mutation leading to disseminated Talaromyces marneffei infection combined with hemophagocytic syndrome: a case report].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2025

Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations.

Life medicine
2025

Unmasking Wiskott-Aldrich Syndrome in Adulthood in a Case of Long-Standing Bleeding, Infections, and Steroid-Induced Morbidity.

Cureus
2026

Case Report: Post-transplant lymphoproliferative disorder after kidney transplantation in a child with schimke immuno-osseous dysplasia.

Frontiers in immunology
2026

[XMEN disease diagnosed following persistent Epstein-Barr virus viremia and recurrent lymphadenopathy].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2026

Demographic, clinical, and immunological features in combined immunodeficiency patients: a comparative analysis of those with and without pulmonary manifestations - a multicenter study from Iran.

BMC pulmonary medicine
2026

Association between gut microbiota-derived TMAO, systemic inflammatory markers, and echocardiographic findings in patients with common variable immunodeficiency.

BMC immunology
2026

Overlapping autoimmunity and immunodeficiency: a case of selective IgA deficiency with autoimmune hemolytic anemia.

BMC pediatrics
2026

Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study.

BMJ open
2026

Neonatal erythroderma and immunodysplasia: Overlap of cartilage-hair hypoplasia and Omenn syndrome.

European journal of medical genetics
2026

Gene alterations in inborn errors of immunity and their presence in cancers: Implications for oncogenesis, progression, and outcomes.

Human immunology
2025

A heterozygous USB1 variant linked to immunodeficiency.

Journal of human immunity
2025

Harmonisation of switched memory B cell analysis for improved CVID diagnosis and classification.

Frontiers in immunology
2025

Case Report: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency.

Frontiers in immunology
2026

Disseminated Mycobacterium abscessus lymphadenopathy in an anti-interferon-γ autoantibody syndrome patient treated with anti-NTM therapy combined with hemoadsorption: A case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency.

Allergy, asthma &amp; immunology research
2025

Activated PI3Kδ syndrome in inborn errors of immunity: diagnostic strategies and clinical challenges.

Frontiers in immunology
2026

Augmenting the Jeffrey Modell Criteria for Optimising Screening for Inborn Errors of Immunity.

Scandinavian journal of immunology
2025

Gastrointestinal Tract Findings in Patients with Primary Immunodeficiency: A Single-Center 6-Year Experience.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
2025

Characteristics of adverse events and clinical risks of intravenous immunoglobulin: a pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS).

Frontiers in medicine
2025

Copy number variation: an important genetic mechanism in SMARCAL1-related immunoosseous dysplasia (Schimke type) in Indian patients.

Journal of genetics
2026

Longitudinally Extensive Transverse Myelitis and Vasculitis by Cryptococcosis in a Non-HIV Patient: A Case Report.

Case reports in neurology
2026

Insights into pulmonary lophomoniasis infection in a Bruton's disease patient; A case report study and literature review.

IDCases
2025

Building alliances for early detection of immunodeficiencies: from primary care to hematology.

Frontiers in immunology
2026

Study of naïve and switched memory B cell level in Egyptian patients with common variable immunodeficiency.

The Egyptian journal of immunology
2026

Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiency.

Molecular therapy. Nucleic acids
2026

Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Nature immunology
2026

[Clinical characteristics of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus infected children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Germline Homozygous RAG1 Missense Variant Associated With Epstein-Barr Virus Negative Childhood Burkitt Lymphoma: A Case Report.

Journal of pediatric hematology/oncology
2025

Granulomatous Lymphocytic Interstitial Lung Disease as the Initial Manifestation of Common Variable Immunodeficiency in a Young Adult.

Cureus
2026

Compassionate Use of Olorofim for Invasive Mold Infections: A Nationwide Observational Study in France.

Open forum infectious diseases
2026

Acyclovir-Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series.

Transplant infectious disease : an official journal of the Transplantation Society
2026

Tuberculosis in Children With Primary Immunodeficiencies: A 13-Year Retrospective Experience.

Pediatric pulmonology
2026

Predictive effect of having a child with primary immunodeficiency on resilience, self-efficacy and spiritual well-being of Turkish parents.

Journal of pediatric nursing
2026

Antibody Deficiency in Xeroderma Pigmentosum.

Journal of clinical immunology
2026

Cartilage-hair hypoplasia in a patient with compound heterozygous variants in the RMRP gene: A case report.

Medicine
2025

Clinical, Genetic, and Immunological Spectrum of CHAI and LATAIE Patients from a Tertiary Referral Centre in India.

International journal of molecular sciences
2026

Risk of atrial fibrillation in primary immunodeficiencies: evaluation of atrial electromechanical delay and P-wave dispersion.

Allergologia et immunopathologia
2026

The relationship between neutropenia and disease prognosis in patients with Common Variable Immunodeficiency (CVID).

Allergologia et immunopathologia
2026

Neonatal-Onset Chronic Granulomatous Disease Presenting With Recurrent Culture-Negative Meningitis: A Case Report and Diagnostic Considerations.

Case reports in immunology
2026

Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice.

The Journal of clinical investigation
2026

Diagnosis of Paediatric Inborn Errors of Immunity in a MENA Cohort Referred for Recurrent Infections Using a Structured Clinical Algorithm: A Real-Life Cross-Sectional Study.

Journal of paediatrics and child health
2026

Primary immunodeficiency disorders increase the risk of postoperative complications following total hip and knee arthroplasty: A national matched cohort study.

Journal of orthopaedics
2026

Griscelli syndrome type 2: A rare case report of pediatric immunodeficiency and neurological implications.

Medicine
2026

Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity.

Journal of clinical immunology
2025

Oral Squamous Cell Carcinoma in a Patient with Myelodysplastic Syndrome: Report of a Case and Literature Review.

Frontiers in dentistry
2026

Downregulation of USP39 in sepsis reflects immune dysfunction and offers diagnostic and prognostic value.

European journal of medical research
2025

Severe SARS-CoV-2 Infection and Campylobacter coli Bacteremia in a Patient With Good's Syndrome.

Cureus
2025

Case Report: Novel variants in the MYD88 gene (c.104T>C, c.141G>C) in a patient with recurrent abscesses as a cause of type 68 immunodeficiency.

Frontiers in immunology
2025

Real-world retrospective cohort study evaluating the tolerability of immune globulin intravenous 10% (BIVIGAM®).

Frontiers in immunology
2025

An integrated platform for concurrent structural and single-nucleotide variants improves copy-number detection and reveals pathogenic alleles in undiagnosed Mendelian families.

Genome medicine
2025

Pulmonary Manifestations of Inborn Errors of Immunity: Diagnostic and Therapeutic Insights.

Life (Basel, Switzerland)
2025

TYK2 Deficiency Presenting as Refractory Disseminated BCG/Tuberculosis Infection in a Kazakh Child: A Case Report with Genetic Confirmation.

Genes
2025

Abnormal immunoglobulin expression and B-cell follicle organization in inborn errors of immunity/primary immunodeficiency.

Virchows Archiv : an international journal of pathology
2026

Refractory/Relapsed Hodgkin Lymphoma in Cartilage Hair Hypoplasia-Anauxetic Dysplasia Spectrum: Long-term HSCT-free Remission in 2 Pediatric Siblings.

Journal of pediatric hematology/oncology
2025

STAT3 c.1915C > T variant-associated Hyper-IgE syndrome in a child: a case report.

Frontiers in pediatrics
2025

Rapidly Progressive Disseminated Bacillus Calmette-Guérin Infection (BCGitis) in a 3-Month-Old Infant Without Immunodeficiency: A Case Report.

The American journal of case reports
2025

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies.

British journal of clinical pharmacology
2025

Age-Related Patterns of Type II Interferon Immunity: Implications for Intramacrophagic Infections and MSMD Diagnosis During Childhood.

Journal of clinical immunology
2026

Immunodeficiency-Associated Childhood Interstitial Lung Diseases: Data from the Türkiye chILD Registry.

Balkan medical journal
2026

WHIM syndrome: from mechanism to targeted therapy - advances shaping clinical care.

Current opinion in allergy and clinical immunology
2025

Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge.

Infection and drug resistance
2026

Primary Hemophagocytic Lymphohistiocytosis: A Severe Immune Dysregulatory Disease with Various Genotypic Features and Outcomes: A Cross-Sectional Study from a Tertiary Pediatric Center.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2025

Human parvovirus B-19 meningitis: a sentinel event unmasking primary immunodeficiency in an infant.

BMJ case reports
2025

[Congenital neutropenia: a clinical case report].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

P13 The cellulitis that wasn't: a case of subcutaneous panniculitis-like T-cell lymphoma in a toddler.

The British journal of dermatology
2025

Anti-interferon-γ Autoantibody-mediated Adult-onset Immunodeficiency with Disseminated Mycobacterium abscessus Complex Infection: A Report of Three Cases.

International journal of mycobacteriology
2025

The T385M STAT1 gain-of-function mutation confers the most severe disease outcomes.

Frontiers in immunology
2025

Case Report: A novel de novo SPI1 mutation identified in a Chinese patient with agammaglobulinemia.

Frontiers in immunology
2025

Mapping the landscape of autoimmunity and autoinflammation in inborn errors of immunity: broad distribution with distinct clustering patterns.

Frontiers in immunology
2025

Exploring the Pathogens in Primary Predominantly Antibody Deficiencies of Unknown Genetic Origin.

Journal of clinical immunology
2025

Efficacy and Safety of Pegfilgrastim in Patients With Severe Congenital Neutropenia.

EJHaem
2026

Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations.

Blood advances
2025

Toll-like Receptors in Inborn Errors of Immunity in Children: Diagnostic Potential and Therapeutic Frontiers-A Review of the Latest Data.

Cells
2025

Efficacy of omalizumab in the treatment of STAT3 loss-of-function mutations associated with autosomal dominant hyperimmunoglobulin E syndrome-a case report.

Translational pediatrics
2025

Network pharmacology identifies AKR1C3 and KYNU as potential targets of Astragalus Membranaceus and Ephedra in pediatric obesity-associated asthma.

Scientific reports
2026

Missense substitutions in the BTB domain of ZBTB24 can lead to protein instability and cause ICF2 syndrome.

Human molecular genetics
2025

Outer membrane protein C (OMPC) epitope of Shigella flexneri 3a as a potential marker of primary immunodeficiencies (PID) and isolated anti-OmpC antibodies as a tool for immunoglobulin replacement therapy.

Frontiers in immunology
2025

Beyond the skin: immunological profiles and infectious complications in ALOX12B-associated autosomal recessive congenital ichthyosis.

Frontiers in immunology
2025

Comprehensive clinical and immunologic characterization of Wiskott-Aldrich syndrome in Iran: a 10-year cohort study.

BMC immunology
2025

Systematic and proactive evaluation of AIRE missense variant effects.

bioRxiv : the preprint server for biology
2025

Granulomatous and Lymphocytic Interstitial Lung Disease in Hyper-IgM Syndrome.

Scandinavian journal of immunology
2025

Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

Clinical reviews in allergy &amp; immunology
2025

Successful Use of Haploidentical HSCT in a Child With Schimke Immuno-Osseous Dysplasia Who Developed PTLD After Kidney Transplantation.

Pediatric transplantation
2025

Disseminated Histoplasmosis and Campylobacter jejuni Bacteremia Coinfection Revealing Autosomal Dominant NFKB1 Deficiency-Related Common Variable Immunodeficiency.

Medical mycology journal
2025

IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot Study.

Journal of clinical immunology
2025

Rare Genetic Variants Underlying Primary Immunodeficiency: Clinical, Pulmonary, and Genetic Insights from Two Pediatric Cases.

Genes
2025

Case Report: A simple case of drug-induced secondary antibody deficiency or a rare primary immune deficiency?

Frontiers in immunology
2025

Acute Flaccid Paralysis in a Vaccinated Child With Primary Immunodeficiency: Difficulties With Diagnostics of Vaccine-Associated Paralytic Poliomyelitis.

Journal of medical virology
2026

The Skin Tells the Story: Early Signs of Inborn Errors of Immunity.

The journal of allergy and clinical immunology. In practice
2025

Current concepts: Common variable immunodeficiency.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2025

Case Report: Atypical extensive orbitofacial tuberculosis extending to the skull base and cavernous sinus revealed major histocompatibility complex class II deficiency in an 11-year-old girl.

Frontiers in pediatrics
2025

Fatal Chronic Varicella-Zoster Viral Infection in a Young Man With Chediak-Higashi Syndrome.

Pediatric dermatology
2025

Clinical Characteristics, Microbiological Profile, and Mortality Predictors in Pediatric Community-Acquired Sepsis: A Single-Center Study.

Turkish archives of pediatrics
2025

Severe Bleeding From Portal Hypertension in a Young Patient With Common Variable Immunodeficiency-Associated Nodular Regenerative Hyperplasia.

ACG case reports journal
2026

Evaluation of an Accelerated Hepatitis B Vaccination Schedule in Post-Hematopoietic Stem Cell Transplant Pediatric Patients.

Pediatric blood &amp; cancer
2025

The unveiled face of IEI: Children Cancer Hospital-Egypt (CCHE-57357) experience.

Frontiers in immunology
2025

Breaking the mold: a case of invasive Medicopsis romeroi pulmonary infection with innovative granulocyte treatment strategy.

ASM case reports
2026

Epidemiology and management of malignancies in patients with inborn errors of immunity-An ESID registry study of 19,959 patients.

The Journal of allergy and clinical immunology
2025

Evaluation of lymphoid defects in specific inborn errors of immunity using a single-tube multicolor flow cytometry assay.

Immunogenetics
2025

[Clinical features and functional validation of IRAK4 gene deficiency].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Broadening the Phenotypic Spectrum of Forkhead Box N1 Gene Mutations.

Cureus
2025

Case Report: A patient with a novel heterozygous IRF8 variant with repeated infection and immune-mediated organ disease, but without disseminated mycobacterial disease despite BCG immunization.

Frontiers in immunology
2025

CVID Enteropathy Associated With Chronic Norovirus Infection: Background, Clinical Features, and Therapeutic Aspects.

Reviews in medical virology
2025

Insights into the clinical spectrum of selective IgA deficiency: Data from two centers.

Allergologia et immunopathologia
2026

Effect of Inflammatory Bowel Disease on Clinical Outcomes of Hematopoietic Cell Transplantation for Inborn Errors of Immunity.

Transplantation and cellular therapy
2025

Progressive multifocal leukoencephalopathy in a young adult with DOCK8 deficiency: a case of JC virus reactivation in primary immunodeficiency.

Journal of neurovirology
2026

Successful Use of Tralokinumab in a Pediatric Patient With STAT3 Hyper-IgE Syndrome Following Dupilumab-Associated Conjunctivitis.

International journal of dermatology
2025

Reference Values for Extended Lymphocyte Subsets in Korean Children: A Multicenter Study Using the EuroFlow PIDOT Panel.

Annals of laboratory medicine
2025

A New Variant in CTLA4 Highlights the Heterogeneous Phenotype of CTLA4 Haploinsufficiency.

Journal of clinical immunology
2025

A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.

Journal of clinical immunology
2025

Combined Immunodeficiency Associated with Two Novel CARMIL2 Mutations: A Case Series.

Journal of clinical immunology
2026

Immunological Characteristics of Triploid Grass Carp (Ctenopharyngodon idella) and evaluation of its phagocytosis in the macrophages of head kidney.

Fish &amp; shellfish immunology
2025

Novel variants related to extreme elevation of serum IgE in Vietnamese patients with primary immunodeficiency: Case report.

Medicine
2026

Compound heterozygous NFKB1 missense variants in cis associated with immunodeficiency.

Clinical immunology (Orlando, Fla.)
2026

Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling.

The Journal of allergy and clinical immunology
2025

Double-hit RAG2 mutation presenting with hyper-immunoglobulin E and preserved T cells diagnostic challenge: a case report.

Journal of medical case reports
2025

Management of the child with primary immunodeficiency.

Current opinion in pediatrics
2025

Contribution of next generation sequencing to the diagnosis of inborn errors of immunity in a pediatric cohort.

Frontiers in immunology
2025

Two novel BACH2 variants presenting as Still's disease with renal thrombotic microangiopathy and immunodeficiency with recurrent infections.

Rheumatology international
2025

A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.

BMC pediatrics
2025

Characteristics of Secondary Malignancy Among Children With Primary Immunodeficiency Disorders in Saudi Arabia.

Cureus
2026

Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry.

Clinical immunology (Orlando, Fla.)
2026

Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiency.

The Journal of allergy and clinical immunology
2025

Hemophagocytic lymphohistiocytosis in 60 Mexican children with chronic granulomatous disease.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Ver todos os 1.632 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Imunodeficiência primária.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Imunodeficiência primária e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Protocolo oficial relacionado (Ministério da Saúde)PCDT: Imunodeficiência Primária Com Defeitos de Anticorpos

Existe um documento oficial para "Imunodeficiência Primária Com Defeitos de Anticorpos". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.

Respostas geradas por IA a partir das fontes citadas

É uma condição congênita na qual o sistema imunológico não atua de forma adequada para proteger o corpo. Ela predispõe o indivíduo a diversas infecções, especialmente no trato respiratório.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 8 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:101997
    Orphanet
  2. GARD:19813
    GARD (NIH)
  3. Q3043160
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Imunodeficiência primária. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/imunodeficiencia-primaria

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Imunodeficiência primária

ORPHA:101997 · MONDO:0003778
🇧🇷 Brasil SUS
CEAF
1AImunoglobulina humana IV1AImunoglobulina humana SC
Geral
Prevalência
1-9 / 100 000
Ensaios
38 ativos
Medicamentos
17 registrados
Prevalência
0.0 (Europe)
MedGen
UMLS
C0021051
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara